Untitled Document
  SciTegic11272416012D

 38 42  0  0  0  0            999 V2000
    0.6592    0.0553    0.0000 N   0  0
    1.3737   -0.3572    0.0000 C   0  0
    1.3737   -1.1822    0.0000 C   0  0
    0.6592   -1.5947    0.0000 C   0  0
   -0.0553   -1.1822    0.0000 C   0  0
   -0.7697   -1.5947    0.0000 C   0  0
   -1.4842   -1.1822    0.0000 C   0  0
   -1.4842   -0.3572    0.0000 N   0  0
   -0.7697    0.0553    0.0000 C   0  0
   -0.0553   -0.3572    0.0000 C   0  0
    2.0881    0.0553    0.0000 O   0  0
   -1.4842   -2.8322    0.0000 C   0  0
   -0.7697   -2.4197    0.0000 C   0  0
   -0.0553   -2.8322    0.0000 C   0  0
   -0.0553   -3.6572    0.0000 C   0  0
   -0.7697   -4.0697    0.0000 C   0  0
   -1.4842   -3.6572    0.0000 N   0  0
    0.6592   -4.0697    0.0000 C   0  0
    2.0881   -1.5947    0.0000 C   0  0
   -0.7697    0.8803    0.0000 N   0  0
   -2.9131    2.1178    0.0000 N   0  0
   -2.1987    2.5303    0.0000 C   0  0
   -1.4842    2.1178    0.0000 C   0  0  2  0  0  0
   -1.4842    1.2928    0.0000 C   0  0  1  0  0  0
   -2.1987    0.8803    0.0000 C   0  0  2  0  0  0
   -2.9131    1.2928    0.0000 C   0  0
   -2.1987    0.0553    0.0000 O   0  0
   -2.9131   -0.3572    0.0000 C   0  0
   -0.7697    2.5303    0.0000 O   0  0
   -0.0553    2.1178    0.0000 C   0  0
    0.6592    2.5303    0.0000 C   0  0
    0.6592    3.3553    0.0000 C   0  0
    1.3737    3.7678    0.0000 C   0  0
    2.0881    3.3553    0.0000 C   0  0
    2.0881    2.5303    0.0000 C   0  0
    1.3737    2.1178    0.0000 C   0  0
    2.9131    3.3553    0.0000 F   0  0
    2.5006    4.0697    0.0000 F   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  1 10  1  0
  5 10  1  0
  2 11  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12 17  2  0
 15 18  1  0
  6 13  1  0
  3 19  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 21 26  1  0
 27 28  1  0
 25 27  1  1
 29 30  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 31 36  1  0
 34 37  1  0
 34 38  1  0
 30 31  1  0
 23 29  1  1
 24 20  1  6
  9 20  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-114204

> <Drug_Names>
GSK8814

> <SYNONYMS>

> <CA_Index_Name>
1,7-Naphthyridin-2(1H)-one, 8-[[(3R,4R,5S)-3-[(4,4-difluorocyclohexyl)methoxy]-5-methoxy-4-piperidinyl]amino]-3-methyl-5-(5-methyl-3-pyridinyl)-

> <CAS>
1997369-78-4

> <MWt>
527.61

> <Formula>
C28H35F2N5O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 47 51  0  0  0  0            999 V2000
    1.2567   -0.8961    0.0000 C   0  0
    0.5422   -1.3086    0.0000 C   0  0
    0.5422   -2.1336    0.0000 C   0  0
   -0.1722   -2.5461    0.0000 C   0  0
   -0.8867   -2.1336    0.0000 C   0  0
   -0.8867   -1.3086    0.0000 C   0  0
   -0.1722   -0.8961    0.0000 C   0  0
    1.2567   -0.0711    0.0000 O   0  0
    1.9712   -1.3086    0.0000 N   0  0
   -2.3549   -1.2317    0.0000 O   0  0
   -1.6012   -0.8961    0.0000 C   0  0
   -1.6874   -0.0756    0.0000 C   0  0
   -2.4944    0.0959    0.0000 C   0  0
   -2.9069   -0.6186    0.0000 C   0  0
   -3.7274   -0.7048    0.0000 C   0  0
   -4.2123   -0.0374    0.0000 N   0  0
   -5.0328   -0.1236    0.0000 C   0  0  2  0  0  0
   -5.3683   -0.8773    0.0000 C   0  0
   -5.5177    0.5438    0.0000 C   0  0
   -6.3382    0.4576    0.0000 C   0  0
   -6.8231    1.1250    0.0000 C   0  0
   -6.4875    1.8787    0.0000 C   0  0
   -5.6671    1.9649    0.0000 C   0  0
   -5.1821    1.2975    0.0000 C   0  0
   -6.9725    2.5461    0.0000 C   0  0
   -1.6012   -2.5461    0.0000 O   0  0
   -2.3157   -2.1336    0.0000 C   0  0
    1.2567   -2.5461    0.0000 Cl  0  0
    2.6856   -0.8961    0.0000 C   0  0  1  0  0  0
    3.4001   -1.3086    0.0000 C   0  0
    2.6856   -0.0711    0.0000 C   0  0
    3.4001    0.3414    0.0000 C   0  0
    3.4001    1.1664    0.0000 C   0  0
    4.1146    1.5789    0.0000 C   0  0
    4.8291    1.1664    0.0000 C   0  0
    4.8291    0.3414    0.0000 C   0  0
    4.1146   -0.0711    0.0000 C   0  0
    5.5435    1.5789    0.0000 C   0  0
    6.2580    1.9914    0.0000 N   0  0
    4.1146   -0.8961    0.0000 N   0  0
    4.8291   -1.3086    0.0000 C   0  0  1  0  0  0
    5.5435   -0.8961    0.0000 C   0  0
    6.2580   -1.3086    0.0000 C   0  0
    6.2580   -2.1336    0.0000 C   0  0  2  0  0  0
    5.5435   -2.5461    0.0000 C   0  0
    4.8291   -2.1336    0.0000 C   0  0
    6.9725   -2.5461    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  2  7  2  0
  1  8  2  0
  1  9  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 10 14  1  0
 17 18  1  6
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 19 24  2  0
 22 25  1  0
 17 19  1  0
 16 17  1  0
 15 16  1  0
 14 15  1  0
  6 11  1  0
 26 27  1  0
  5 26  1  0
  3 28  1  0
 29 30  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 32 37  2  0
 38 39  3  0
 35 38  1  0
 31 32  1  0
 29 31  1  6
 41 42  1  0
 42 43  1  0
 43 44  1  0
 44 45  1  0
 45 46  1  0
 41 46  1  0
 44 47  1  1
 41 40  1  1
 30 40  1  0
  9 29  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-119254

> <Drug_Names>
BAY-850

> <SYNONYMS>

> <CA_Index_Name>
Benzamide, N-[(1R)-2-[(cis-4-aminocyclohexyl)amino]-1-[(4-cyanophenyl)methyl]ethyl]-2-chloro-4-methoxy-5-[5-[[[(1R)-1-(4-methylphenyl)ethyl]amino]methyl]-2-furanyl]-

> <CAS>
2099142-76-2

> <MWt>
654.24

> <Formula>
C38H44ClN5O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Metabolic Disease

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 31 34  0  0  0  0            999 V2000
    1.1259    2.4205    0.0000 O   0  0
    1.5384    1.7060    0.0000 C   0  0
    2.3634    1.7060    0.0000 O   0  0
    2.7759    2.4205    0.0000 C   0  0
    2.3634    3.1350    0.0000 C   0  0
    3.1884    3.1350    0.0000 C   0  0
    3.6009    2.4205    0.0000 C   0  0
    1.1259    0.9915    0.0000 C   0  0
    0.3009    0.9915    0.0000 C   0  0  1  0  0  0
   -0.0570    1.7348    0.0000 C   0  0
    0.3661    2.4431    0.0000 N   0  0
   -0.1767    3.0643    0.0000 N   0  0
   -0.9353    2.7401    0.0000 C   0  0
   -1.6498    3.1526    0.0000 C   0  0
   -0.8614    1.9184    0.0000 N   0  0
   -1.5064    1.4040    0.0000 C   0  0
   -1.5064    0.5790    0.0000 C   0  0
   -2.2910    0.3241    0.0000 C   0  0
   -2.5459   -0.4605    0.0000 C   0  0
   -2.7759    0.9915    0.0000 C   0  0
   -3.6009    0.9915    0.0000 C   0  0
   -2.2910    1.6590    0.0000 S   0  0
   -0.8614    0.0647    0.0000 C   0  0
   -1.0449   -0.7397    0.0000 C   0  0
   -0.4402   -1.3008    0.0000 C   0  0
   -0.6237   -2.1051    0.0000 C   0  0
   -1.4121   -2.3483    0.0000 C   0  0
   -1.5957   -3.1526    0.0000 Cl  0  0
   -2.0169   -1.7871    0.0000 C   0  0
   -1.8333   -0.9828    0.0000 C   0  0
   -0.0570    0.2482    0.0000 N   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  2  8  1  0
  9  8  1  6
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 10 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 21  1  0
 20 22  1  0
 16 22  1  0
 17 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 27 29  1  0
 29 30  2  0
 24 30  1  0
 23 31  2  0
  9 31  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-13030

> <Drug_Names>
(+)-JQ-1

> <SYNONYMS>
JQ1

> <CA_Index_Name>
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-trimethyl-, 1,1-dimethylethyl ester, (6S)-

> <CAS>
1268524-70-4

> <MWt>
456.99

> <Formula>
C23H25ClN4O2S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Autophagy; Epigenetic Reader Domain; Ligands for Target Protein for PROTAC

> <Pathway>
Autophagy; Epigenetics; PROTAC

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 38 43  0  0  0  0            999 V2000
   -3.1554   -2.8830    0.0000 N   0  0
   -3.5200   -2.1430    0.0000 O   0  0
   -2.9288   -1.5675    0.0000 C   0  0
   -2.1988   -1.9520    0.0000 C   0  0
   -2.3389   -2.7650    0.0000 C   0  0
   -1.7635   -3.3562    0.0000 C   0  0
   -3.0468   -0.7510    0.0000 C   0  0
    0.8749   -2.0307    0.0000 N   0  0
    1.6149   -1.6661    0.0000 C   0  0
    1.6692   -0.8429    0.0000 C   0  0
    0.9835   -0.3843    0.0000 C   0  0
    0.2434   -0.7489    0.0000 C   0  0
   -0.4424   -0.2902    0.0000 C   0  0
   -1.1824   -0.6548    0.0000 C   0  0
   -1.2367   -1.4780    0.0000 C   0  0
   -0.5510   -1.9366    0.0000 C   0  0
    0.1891   -1.5721    0.0000 C   0  0
    2.0321    0.4417    0.0000 C   0  0
    2.3173   -0.3324    0.0000 N   0  0
    1.2077    0.4097    0.0000 N   0  0
    0.6973    1.0578    0.0000 C   0  0  1  0  0  0
    1.0033    1.8239    0.0000 C   0  0
    2.4907    1.1275    0.0000 C   0  0
    3.3140    1.0732    0.0000 O   0  0
    3.7726    1.7590    0.0000 C   0  0
    1.8198    1.9419    0.0000 C   0  0
    2.1258    2.7081    0.0000 C   0  0
    1.6153    3.3562    0.0000 C   0  0
    0.7988    3.2381    0.0000 C   0  0
    0.4928    2.4720    0.0000 C   0  0
   -0.1193    0.9397    0.0000 C   0  0
   -1.8682   -0.1962    0.0000 O   0  0
   -1.8139    0.6270    0.0000 C   0  0
   -2.4997    1.0857    0.0000 C   0  0  2  0  0  0
   -2.5065    1.9106    0.0000 C   0  0
   -3.2932    2.1591    0.0000 N   0  0
   -3.7726    1.4877    0.0000 C   0  0
   -3.2932    0.8243    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  1  5  2  0
  5  6  1  0
  3  7  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  8 17  1  0
 12 17  1  0
 18 19  2  0
 18 20  1  0
 19 10  1  0
 20 11  1  0
 21 22  1  0
 20 21  1  0
 24 25  1  0
 23 24  1  0
 18 23  1  0
  4 15  1  0
 22 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 22  1  0
 21 31  1  6
 14 32  1  0
 32 33  1  0
 34 33  1  1
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 34  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-136570

> <Drug_Names>
GSK778

> <SYNONYMS>
iBET-BD1

> <CA_Index_Name>
4-(2-(Methoxymethyl)-1-((R)-1-phenylethyl)-8-(((S)-pyrrolidin-3-yl)methoxy)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole

> <CAS>
2451862-42-1

> <MWt>
511.61

> <Formula>
C30H33N5O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer; Inflammation/Immunology

> <Target>
Apoptosis; Epigenetic Reader Domain

> <Pathway>
Apoptosis; Epigenetics

> <Concentration>

$$$$
Untitled Document
  SciTegic11272416012D

 30 32  0  0  0  0            999 V2000
   -0.7145    0.0000    0.0000 C   0  0
    0.0000   -0.4125    0.0000 C   0  0
    0.0000   -1.2375    0.0000 C   0  0
    0.7145   -1.6500    0.0000 C   0  0
    1.4289   -1.2375    0.0000 C   0  0
    1.4289   -0.4125    0.0000 C   0  0
    0.7145    0.0000    0.0000 C   0  0
   -0.7145    0.8250    0.0000 O   0  0
   -1.4289   -0.4125    0.0000 N   0  0
    2.1434    0.0000    0.0000 O   0  0
    2.1434    0.8250    0.0000 C   0  0  1  0  0  0
    1.4289    1.2375    0.0000 C   0  0
    2.8579    1.2375    0.0000 C   0  0
    2.8579    2.0625    0.0000 C   0  0
    3.5724    2.4750    0.0000 C   0  0
    4.2868    2.0625    0.0000 C   0  0
    4.2868    1.2375    0.0000 C   0  0
    3.5724    0.8250    0.0000 C   0  0
   -2.1434    0.0000    0.0000 C   0  0  1  0  0  0
   -2.8579   -0.4125    0.0000 C   0  0
   -3.5724    0.0000    0.0000 C   0  0
   -3.5724    0.8250    0.0000 C   0  0  1  0  0  0
   -2.8579    1.2375    0.0000 C   0  0
   -2.1434    0.8250    0.0000 C   0  0
   -4.2868    1.2375    0.0000 O   0  0
    0.7145   -2.4750    0.0000 F   0  0
    2.8579   -1.2375    0.0000 C   0  0
    3.5724   -1.6500    0.0000 C   0  0
    2.8579   -0.4125    0.0000 O   0  0
    2.1434   -1.6500    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  2  7  2  0
  1  8  2  0
  1  9  1  0
 11 12  1  1
 10 11  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 13 18  2  0
 11 13  1  0
  6 10  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 19 24  1  0
 22 25  1  6
 19  9  1  1
  4 26  1  0
 27 28  1  0
 27 29  2  0
 27 30  1  0
  5 30  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-136571

> <Drug_Names>
GSK046

> <SYNONYMS>
iBET-BD2

> <CA_Index_Name>
4-Acetamido-3-fluoro-N-((1r,4S)-4-hydroxycyclohexyl)-5-((S)-1-phenylethoxy)benzamide

> <CAS>
2474876-09-8

> <MWt>
414.47

> <Formula>
C23H27FN2O4

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Inflammation/Immunology

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 24 26  0  0  0  0            999 V2000
    1.1270    0.4125    0.0000 C   0  0
    1.1270    1.2375    0.0000 C   0  0
    0.4125    1.6500    0.0000 C   0  0
   -0.3020    1.2375    0.0000 C   0  0
   -0.3020    0.4125    0.0000 C   0  0
    0.4125    0.0000    0.0000 N   0  0
    1.8414    1.6500    0.0000 C   0  0
    1.8414    2.4750    0.0000 O   0  0
    2.5559    1.2375    0.0000 N   0  0
   -1.0164    1.6500    0.0000 C   0  0
   -1.0164    2.4750    0.0000 O   0  0
   -1.7309    1.2375    0.0000 N   0  0
    0.4125   -0.8250    0.0000 C   0  0
   -0.3020   -1.2375    0.0000 C   0  0
   -0.3020   -2.0625    0.0000 C   0  0
   -1.0164   -2.4750    0.0000 C   0  0
   -1.7309   -2.0625    0.0000 C   0  0
   -1.7309   -1.2375    0.0000 C   0  0
   -1.0164   -0.8250    0.0000 C   0  0
    1.8414    0.0000    0.0000 O   0  0
    3.2704    1.6500    0.0000 C   0  0
   -2.4454    1.6500    0.0000 C   0  0
   -3.2704    1.6500    0.0000 C   0  0
   -2.8579    2.3645    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  1  0
  7  8  2  0
  7  9  1  0
  2  7  1  0
 10 11  2  0
 10 12  1  0
  4 10  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 14 19  2  0
 13 14  1  0
  6 13  1  0
  1 20  2  0
  9 21  1  0
 22 23  1  0
 23 24  1  0
 22 24  1  0
 12 22  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-137892

> <Drug_Names>
GSK620

> <SYNONYMS>

> <CA_Index_Name>
3,5-Pyridinedicarboxamide, N5-cyclopropyl-1,2-dihydro-N3-methyl-2-oxo-1-(phenylmethyl)-

> <CAS>
2088410-46-0

> <MWt>
325.36

> <Formula>
C18H19N3O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Inflammation/Immunology

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 27 30  0  0  0  0            999 V2000
    2.6526    0.9580    0.0000 C   0  0
    1.9382    0.5455    0.0000 C   0  0
    1.9382   -0.2795    0.0000 C   0  0
    1.2237   -0.6920    0.0000 C   0  0
    0.5092   -0.2795    0.0000 C   0  0
    0.5092    0.5455    0.0000 C   0  0
    1.2237    0.9580    0.0000 C   0  0
    3.3671    1.3705    0.0000 N   0  0
   -1.5109   -0.9695    0.0000 C   0  0
   -1.0984   -1.6840    0.0000 N   0  0
   -0.2915   -1.5125    0.0000 C   0  0
   -0.2052   -0.6920    0.0000 C   0  0
   -0.9589   -0.3564    0.0000 N   0  0
   -1.1304    0.4505    0.0000 C   0  0
   -1.9151    0.7055    0.0000 C   0  0
   -2.7540    2.6685    0.0000 N   0  0
   -1.9471    2.8400    0.0000 N   0  0
   -1.5346    2.1256    0.0000 C   0  0
   -2.0866    1.5125    0.0000 C   0  0
   -2.8403    1.8480    0.0000 C   0  0
   -3.3671    3.2205    0.0000 C   0  0
    1.5411   -2.6074    0.0000 N   0  0
    0.9891   -3.2205    0.0000 N   0  0
    0.2354   -2.8850    0.0000 C   0  0
    0.3216   -2.0645    0.0000 C   0  0
    1.1286   -1.8930    0.0000 C   0  0
    2.3616   -2.6937    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  2  7  2  0
  1  8  3  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
  9 13  1  0
 14 15  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 16 20  1  0
 16 21  1  0
 15 19  1  0
 13 14  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 22 26  1  0
 22 27  1  0
 11 25  1  0
  5 12  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-19336

> <Drug_Names>
BAZ2-ICR

> <SYNONYMS>

> <CA_Index_Name>
Benzonitrile, 4-[4-(1-methyl-1H-pyrazol-4-yl)-1-[2-(1-methyl-1H-pyrazol-4-yl)ethyl]-1H-imidazol-5-yl]-

> <CAS>
1665195-94-7

> <MWt>
357.41

> <Formula>
C20H19N7

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 26 28  0  0  0  0            999 V2000
   -0.8905   -0.0666    0.0000 C   0  0
   -0.8905   -0.8916    0.0000 C   0  0
   -0.1760   -1.3045    0.0000 C   0  0
    0.5385   -0.8916    0.0000 N   0  0
    0.5385   -0.0666    0.0000 C   0  0
   -0.1760    0.3459    0.0000 C   0  0
    1.3235   -1.1470    0.0000 C   0  0
    1.8084   -0.4791    0.0000 C   0  0
    1.3235    0.1883    0.0000 C   0  0
    1.5776   -1.9289    0.0000 C   0  0
    1.0274   -2.5398    0.0000 O   0  0
    2.3817   -2.0998    0.0000 C   0  0
   -1.6028    0.3444    0.0000 O   0  0
   -2.3148   -0.0666    0.0000 C   0  0
   -3.0272    0.3444    0.0000 C   0  0
   -3.7392   -0.0666    0.0000 C   0  0
    1.5776    0.9706    0.0000 C   0  0
    2.3845    1.1421    0.0000 C   0  0
    2.6395    1.9267    0.0000 C   0  0
    2.0874    2.5398    0.0000 C   0  0
    1.2805    2.3683    0.0000 C   0  0
    1.0255    1.5837    0.0000 C   0  0
    2.9351    0.5308    0.0000 S   0  0
    2.6806   -0.2511    0.0000 O   0  0
    3.7392    0.7017    0.0000 O   0  0
    3.1891    1.3131    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  1  2  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  2  0
  7 10  1  0
 10 11  2  0
 10 12  1  0
  1 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  9 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 18 23  1  0
 23 24  2  0
 23 25  2  0
 23 26  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-15658

> <Drug_Names>
GSK2801

> <SYNONYMS>

> <CA_Index_Name>
Ethanone, 1-[1-[2-(methylsulfonyl)phenyl]-7-propoxy-3-indolizinyl]-

> <CAS>
1619994-68-1

> <MWt>
371.45

> <Formula>
C20H21NO4S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Apoptosis; Epigenetic Reader Domain

> <Pathway>
Apoptosis; Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 26 28  0  0  0  0            999 V2000
   -1.4289    0.0000    0.0000 C   0  0
   -1.4289   -0.8250    0.0000 C   0  0
   -0.7145   -1.2375    0.0000 C   0  0
    0.0000   -0.8250    0.0000 C   0  0
    0.0000    0.0000    0.0000 C   0  0
   -0.7145    0.4125    0.0000 C   0  0
   -2.1433   -1.2375    0.0000 C   0  0
   -2.1433   -2.0624    0.0000 N   0  0
   -2.8578   -2.4749    0.0000 C   0  0
   -1.4289   -2.4749    0.0000 C   0  0
   -0.7145   -2.0624    0.0000 O   0  0
    0.0000   -2.4749    0.0000 C   0  0
    0.7145    0.4125    0.0000 C   0  0
    1.4289    0.0000    0.0000 C   0  0
    2.1433    0.4125    0.0000 C   0  0
    2.1433    1.2375    0.0000 C   0  0
    1.4289    1.6500    0.0000 N   0  0
    0.7145    1.2375    0.0000 C   0  0
    1.4289   -0.8250    0.0000 C   0  0
    2.1433   -1.2375    0.0000 C   0  0
    2.8578   -0.8250    0.0000 N   0  0
    2.8578    0.0000    0.0000 C   0  0
    1.4289    2.4749    0.0000 C   0  0
    2.8578    1.6500    0.0000 O   0  0
   -0.7145    1.2375    0.0000 O   0  0
    0.0000    1.6500    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
  3 11  1  0
 11 12  1  0
  5 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 13  2  0
 14 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 15  1  0
 17 23  1  0
 16 24  2  0
  6 25  1  0
 25 26  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-100352

> <Drug_Names>
BI-9564

> <SYNONYMS>

> <CA_Index_Name>
4-(4-((dimethylamino)methyl)-2,5-dimethoxyphenyl)-2-methyl-2,7-naphthyridin-1(2H)-one

> <CAS>
1883429-22-8

> <MWt>
353.41

> <Formula>
C20H23N3O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 25 28  0  0  0  0            999 V2000
   -2.4447    1.7721    0.0000 C   0  0
   -2.4447    0.9471    0.0000 C   0  0
   -1.7302    0.5346    0.0000 N   0  0
   -1.0158    0.9471    0.0000 C   0  0
   -1.0158    1.7721    0.0000 N   0  0
   -1.7302    2.1846    0.0000 C   0  0
   -0.2311    0.6922    0.0000 C   0  0
    0.2538    1.3596    0.0000 C   0  0
   -0.2311    2.0271    0.0000 C   0  0
    0.0238    2.8117    0.0000 C   0  0
   -0.5282    3.4248    0.0000 O   0  0
    0.8308    2.9832    0.0000 C   0  0
    0.0238   -0.0924    0.0000 C   0  0
   -0.5282   -0.7055    0.0000 C   0  0
   -0.2733   -1.4901    0.0000 C   0  0
    0.5337   -1.6617    0.0000 C   0  0
    1.0857   -1.0486    0.0000 C   0  0
    0.8308   -0.2640    0.0000 C   0  0
   -1.3352   -0.5340    0.0000 C   0  0
    1.8927   -1.2201    0.0000 C   0  0
    2.4447   -0.6070    0.0000 O   0  0
    2.1476   -2.0047    0.0000 N   0  0
    1.5956   -2.6178    0.0000 C   0  0
    0.8110   -2.8728    0.0000 C   0  0
    1.4241   -3.4248    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  1  2  0
  4  7  2  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  7 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 14 19  1  0
 17 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 23  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-100517

> <Drug_Names>
TP-472

> <SYNONYMS>

> <CA_Index_Name>
Benzamide, 3-(6-acetylpyrrolo[1,2-a]pyrimidin-8-yl)-N-cyclopropyl-4-methyl-

> <CAS>
2079895-62-6

> <MWt>
333.38

> <Formula>
C20H19N3O2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Apoptosis; Epigenetic Reader Domain

> <Pathway>
Apoptosis; Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 33 36  0  0  0  0            999 V2000
   -2.1338   -2.0625    0.0000 C   0  0
   -1.4193   -1.6500    0.0000 C   0  0
   -1.4193   -0.8250    0.0000 C   0  0
   -2.1338   -0.4125    0.0000 C   0  0
   -2.8483   -0.8250    0.0000 C   0  0
   -2.8483   -1.6500    0.0000 N   0  0
   -0.6347   -1.9049    0.0000 C   0  0
   -0.1498   -1.2375    0.0000 C   0  0
   -0.6347   -0.5701    0.0000 S   0  0
    0.6752   -1.2375    0.0000 C   0  0
    1.0877   -1.9520    0.0000 N   0  0
    1.0877   -0.5230    0.0000 N   0  0
   -2.1338    0.4125    0.0000 C   0  0
   -2.8483    0.8250    0.0000 C   0  0
   -2.8483    1.6500    0.0000 C   0  0
   -2.1338    2.0625    0.0000 C   0  0
   -1.4193    1.6500    0.0000 C   0  0
   -1.4193    0.8250    0.0000 C   0  0
   -3.5627    2.0625    0.0000 C   0  0
   -3.5627    2.8875    0.0000 F   0  0
   -4.2772    2.4750    0.0000 F   0  0
   -4.2772    1.6500    0.0000 F   0  0
    3.1502   -1.2375    0.0000 C   0  0
    2.3252   -1.2375    0.0000 C   0  0
    1.9127   -0.5230    0.0000 C   0  0
    2.3252    0.1914    0.0000 C   0  0
    3.1502    0.1914    0.0000 C   0  0
    3.5627   -0.5230    0.0000 S   0  0
    4.2772   -0.9355    0.0000 O   0  0
    4.2772   -0.1105    0.0000 O   0  0
   -2.1338   -2.8875    0.0000 O   0  0
   -3.5627   -2.0625    0.0000 C   0  0
   -4.2772   -1.6500    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  1  0
  7  8  2  0
  8  9  1  0
  2  7  1  0
  3  9  1  0
 10 11  2  0
 10 12  1  0
  8 10  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 13 18  2  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
 15 19  1  0
  4 13  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 23 28  1  0
 28 29  2  0
 28 30  2  0
 12 25  1  0
  1 31  2  0
 32 33  1  0
  6 32  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-18975

> <Drug_Names>
I-BRD9

> <SYNONYMS>

> <CA_Index_Name>
Thieno[3,2-c]pyridine-2-carboximidamide, 5-ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]-

> <CAS>
1714146-59-4

> <MWt>
497.55

> <Formula>
C22H22F3N3O3S2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer; Inflammation/Immunology

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 26 28  0  0  0  0            999 V2000
   -1.4045    0.7260    0.0000 C   0  0
   -2.1190    1.1385    0.0000 C   0  0
   -2.1190    1.9635    0.0000 C   0  0
   -1.4045    2.3760    0.0000 C   0  0
   -0.6900    1.9635    0.0000 C   0  0
   -0.6900    1.1385    0.0000 C   0  0
   -1.4045   -0.0990    0.0000 S   0  0
   -2.2295   -0.0990    0.0000 O   0  0
   -0.5795   -0.0990    0.0000 O   0  0
   -1.4045   -0.9240    0.0000 N   0  0
   -2.8335    0.7260    0.0000 C   0  0
    2.0085   -1.7490    0.0000 C   0  0
    1.5235   -1.0815    0.0000 N   0  0
    0.7389   -1.3365    0.0000 C   0  0
    0.7389   -2.1615    0.0000 C   0  0
    1.5235   -2.4164    0.0000 N   0  0
    0.0244   -0.9240    0.0000 C   0  0
   -0.6900   -1.3365    0.0000 C   0  0
   -0.6900   -2.1615    0.0000 C   0  0
    0.0244   -2.5740    0.0000 C   0  0
    2.8335   -1.7490    0.0000 O   0  0
    1.7785   -0.2969    0.0000 C   0  0
    1.7785   -3.2010    0.0000 C   0  0
   -1.4045   -2.5740    0.0000 O   0  0
   -2.1190   -2.1615    0.0000 C   0  0
   -1.4045    3.2010    0.0000 Br  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  2  0
  7  8  2  0
  7  9  2  0
  7 10  1  0
  1  7  1  0
  2 11  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 12 16  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 15 20  2  0
 14 17  2  0
 12 21  2  0
 13 22  1  0
 16 23  1  0
 24 25  1  0
 19 24  1  0
 10 18  1  0
  4 26  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-12518

> <Drug_Names>
OF-1

> <SYNONYMS>

> <CA_Index_Name>
Benzenesulfonamide, 4-bromo-N-(2,3-dihydro-6-methoxy-1,3-dimethyl-2-oxo-1H-benzimidazol-5-yl)-2-methyl-

> <CAS>
919973-83-4

> <MWt>
440.31

> <Formula>
C17H18BrN3O4S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 27 29  0  0  0  0            999 V2000
   -3.5724    0.4125    0.0000 C   0  0
   -3.5724   -0.4125    0.0000 C   0  0
   -2.8579   -0.8250    0.0000 N   0  0
   -2.1434   -0.4125    0.0000 C   0  0
   -2.1434    0.4125    0.0000 C   0  0
   -2.8579    0.8250    0.0000 C   0  0
   -1.4289   -0.8250    0.0000 C   0  0
   -0.7145   -0.4125    0.0000 C   0  0
   -0.7145    0.4125    0.0000 C   0  0
   -1.4289    0.8250    0.0000 C   0  0
    0.0000    0.8250    0.0000 N   0  0
    0.7145    0.4125    0.0000 S   0  0
    1.4289    0.0000    0.0000 C   0  0
    1.4289   -0.8250    0.0000 C   0  0
    2.1434   -1.2375    0.0000 C   0  0
    2.8579   -0.8250    0.0000 C   0  0
    2.8579    0.0000    0.0000 C   0  0
    2.1434    0.4125    0.0000 C   0  0
    2.1434    1.2375    0.0000 O   0  0
    1.4289    1.6500    0.0000 C   0  0
   -4.2868    0.8250    0.0000 C   0  0
   -4.2868   -0.8250    0.0000 O   0  0
   -2.8579   -1.6500    0.0000 C   0  0
    0.3020   -0.3020    0.0000 O   0  0
    1.1270    1.1270    0.0000 O   0  0
    3.5724   -1.2375    0.0000 C   0  0
    4.2868   -1.6500    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  1  2  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 18 19  1  0
 19 20  1  0
 16 26  1  0
  1 21  1  0
  2 22  2  0
  3 23  1  0
 12 24  2  0
 12 25  2  0
 26 27  3  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-19537

> <Drug_Names>
NI-57

> <SYNONYMS>

> <CA_Index_Name>
Benzenesulfonamide, 4-cyano-N-(1,2-dihydro-1,3-dimethyl-2-oxo-6-quinolinyl)-2-methoxy-

> <CAS>
1883548-89-7

> <MWt>
383.42

> <Formula>
C19H17N3O4S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer; Inflammation/Immunology

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 30 33  0  0  0  0            999 V2000
   -2.4762   -2.2687    0.0000 N   0  0
   -1.7617   -2.6812    0.0000 C   0  0
   -1.0473   -2.2687    0.0000 C   0  0  2  0  0  0
   -1.0473   -1.4438    0.0000 N   0  0
   -1.7617   -1.0313    0.0000 C   0  0
   -2.4762   -1.4438    0.0000 C   0  0
   -0.3328   -2.6812    0.0000 C   0  0
    2.3657   -0.6188    0.0000 C   0  0
    1.8807    0.0487    0.0000 N   0  0
    1.0961   -0.2062    0.0000 C   0  0
    1.0961   -1.0313    0.0000 C   0  0
    1.8807   -1.2862    0.0000 N   0  0
    0.3816   -1.4438    0.0000 C   0  0
   -0.3328   -1.0313    0.0000 C   0  0
   -0.3328   -0.2062    0.0000 C   0  0
    0.3816    0.2062    0.0000 C   0  0
    3.1907   -0.6188    0.0000 O   0  0
   -1.0473    0.2062    0.0000 N   0  0
    2.1357   -2.0708    0.0000 C   0  0
    2.1357    0.8333    0.0000 C   0  0
   -1.0473    1.0313    0.0000 C   0  0
   -1.7617    1.4438    0.0000 C   0  0
   -2.4762    1.0313    0.0000 C   0  0
   -3.1907    1.4438    0.0000 C   0  0
   -3.1907    2.2687    0.0000 C   0  0
   -2.4762    2.6812    0.0000 C   0  0
   -1.7617    2.2687    0.0000 C   0  0
   -0.3328    1.4438    0.0000 O   0  0
   -2.4762    0.2062    0.0000 O   0  0
   -1.7617   -0.2062    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  3  7  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  8 12  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 10  2  0
 13 11  2  0
  8 17  2  0
 15 18  1  0
 12 19  1  0
  9 20  1  0
  4 14  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 22 27  2  0
 21 28  2  0
 29 30  1  0
 23 29  1  0
 21 18  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-100220

> <Drug_Names>
GSK6853

> <SYNONYMS>

> <CA_Index_Name>
Benzamide, N-[2,3-dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxy-

> <CAS>
1910124-24-1

> <MWt>
409.48

> <Formula>
C22H27N5O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 32 36  0  0  0  0            999 V2000
   -0.9213    0.9038    0.0000 O   0  0
   -0.5096    0.1919    0.0000 C   0  0
   -0.9213   -0.5280    0.0000 C   0  0
   -0.5096   -1.2359    0.0000 C   0  0
    0.3154   -1.2359    0.0000 C   0  0
    0.7287   -0.5280    0.0000 C   0  0
    0.3154    0.1919    0.0000 N   0  0
    1.0298    0.6015    0.0000 C   0  0
    1.7463    0.1919    0.0000 C   0  0
    2.4608    0.6015    0.0000 C   0  0
    2.4608    1.4309    0.0000 C   0  0
    1.7463    1.8425    0.0000 C   0  0
    1.0298    1.4309    0.0000 C   0  0
    0.3154    1.8425    0.0000 C   0  0
    3.1771    1.8425    0.0000 N   0  0
    3.8897    1.4309    0.0000 C   0  0
    3.8897    0.6015    0.0000 N   0  0
    4.4729    0.0229    0.0000 C   0  0
    4.6041    1.8425    0.0000 O   0  0
    3.1771    2.6638    0.0000 C   0  0
    1.5537   -0.5280    0.0000 O   0  0
    0.7287   -1.9559    0.0000 C   0  0
    0.3154   -2.6638    0.0000 C   0  0
   -0.5096   -2.6638    0.0000 C   0  0
   -0.9213   -1.9559    0.0000 C   0  0
   -1.7463   -1.9559    0.0000 C   0  0
   -2.1596   -1.2359    0.0000 C   0  0
   -1.7463   -0.5280    0.0000 C   0  0
   -2.4608   -2.3675    0.0000 C   0  0
   -3.1752   -1.9559    0.0000 C   0  0
   -3.8897   -2.3675    0.0000 C   0  0
   -4.6041   -1.9559    0.0000 O   0  0
  1  2  2  0
  2  3  1  0
  2  7  1  0
  3  4  1  0
  3 28  2  0
  4  5  1  0
  4 25  2  0
  6  5  1  0
  5 22  2  0
  7  6  1  0
  6 21  2  0
  7  8  1  0
  8  9  1  0
  8 13  2  0
  9 10  2  0
 10 11  1  0
 10 17  1  0
 12 11  2  0
 11 15  1  0
 13 12  1  0
 13 14  1  0
 15 16  1  0
 15 20  1  0
 17 16  1  0
 16 19  2  0
 17 18  1  0
 22 23  1  0
 24 23  2  0
 25 24  1  0
 25 26  1  0
 27 26  2  0
 26 29  1  0
 28 27  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-107424

> <Drug_Names>
BAY-299

> <SYNONYMS>

> <CA_Index_Name>
1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-(2,3-dihydro-1,3,6-trimethyl-2-oxo-1H-benzimidazol-5-yl)-6-(3-hydroxypropyl)-

> <CAS>
2080306-23-4

> <MWt>
429.47

> <Formula>
C25H23N3O4

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 34 35  0  0  0  0            999 V2000
   -3.2091    1.6633    0.0000 C   0  0
   -3.2091    0.8383    0.0000 N   0  0
   -2.4947    0.4257    0.0000 C   0  0
   -1.7801    0.8383    0.0000 C   0  0
   -1.7801    1.6633    0.0000 C   0  0
   -2.4947    2.0759    0.0000 N   0  0
   -1.0681    2.0744    0.0000 C   0  0
   -0.3535    1.6618    0.0000 C   0  0
    0.3610    2.0744    0.0000 C   0  0
    0.3610    2.8994    0.0000 C   0  0
   -0.3535    3.3119    0.0000 C   0  0
   -1.0681    2.8994    0.0000 C   0  0
    1.0730    3.3105    0.0000 O   0  0
    1.7850    2.8994    0.0000 C   0  0
    2.4971    3.3105    0.0000 C   0  0
    3.2091    2.8994    0.0000 C   0  0
    3.9212    3.3105    0.0000 N   0  0
    4.6332    2.8994    0.0000 C   0  0
    3.9212    4.1327    0.0000 C   0  0
   -3.9212    2.0744    0.0000 S   0  0
   -4.6332    2.4855    0.0000 O   0  0
   -4.3323    1.3623    0.0000 O   0  0
   -3.5101    2.7864    0.0000 C   0  0
   -2.4947   -0.3965    0.0000 N   0  0
   -1.7826   -0.8076    0.0000 C   0  0
   -1.7826   -1.6298    0.0000 C   0  0
   -1.0706   -2.0410    0.0000 C   0  0
   -1.0706   -2.8631    0.0000 N   0  0
   -1.7380   -3.3481    0.0000 N   0  0
   -1.4831   -4.1327    0.0000 C   0  0
   -0.6581   -4.1327    0.0000 C   0  0
   -0.4030   -3.3481    0.0000 C   0  0
    1.8455   -1.0268    0.0000 H   0  0
    2.6706   -1.0268    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  1  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  7  2  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
  1 20  1  0
 20 21  2  0
 20 22  2  0
 20 23  1  0
  3 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 28  1  0
 33 34  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-114205A

> <Drug_Names>
TP-238 (hydrochloride)

> <SYNONYMS>

> <CA_Index_Name>
4-Pyrimidinamine, 6-[4-[3-(dimethylamino)propoxy]phenyl]-2-(methylsulfonyl)-N-[3-(1H-pyrazol-1-yl)propyl]-, hydrochloride (1:1)

> <CAS>
2415263-05-5

> <MWt>
495.04

> <Formula>
C22H31ClN6O3S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 36 40  0  0  0  0            999 V2000
   -0.6006   -0.2225    0.0000 N   0  0
   -0.1157   -0.8900    0.0000 C   0  0
   -0.6006   -1.5574    0.0000 N   0  0
   -1.3852   -1.3025    0.0000 C   0  0
   -1.3852   -0.4775    0.0000 C   0  0
   -2.0997   -1.7150    0.0000 C   0  0
   -2.8142   -1.3025    0.0000 C   0  0
   -2.8142   -0.4775    0.0000 C   0  0
   -2.0997   -0.0650    0.0000 C   0  0
   -0.3457    0.5621    0.0000 C   0  0
    0.4613    0.7336    0.0000 C   0  0  2  0  0  0
    1.0134    0.1205    0.0000 C   0  0
    0.7163    1.5182    0.0000 N   0  0
    0.1642    2.1313    0.0000 C   0  0
    0.4192    2.9160    0.0000 C   0  0
    1.2261    3.0875    0.0000 O   0  0
    1.7782    2.4744    0.0000 C   0  0
    1.5232    1.6898    0.0000 C   0  0
   -4.4218   -2.7070    0.0000 O   0  0
   -4.8343   -1.9925    0.0000 N   0  0
   -4.2823   -1.3794    0.0000 C   0  0
   -3.5286   -1.7150    0.0000 C   0  0
   -3.6149   -2.5355    0.0000 C   0  0
   -4.4538   -0.5724    0.0000 C   0  0
   -3.0018   -3.0875    0.0000 C   0  0
    0.7093   -0.8900    0.0000 C   0  0
    1.1218   -1.6044    0.0000 C   0  0
    1.9468   -1.6044    0.0000 C   0  0
    2.3593   -0.8900    0.0000 C   0  0
    3.1843   -0.8900    0.0000 C   0  0
    3.5968   -1.6044    0.0000 C   0  0
    3.1843   -2.3189    0.0000 C   0  0
    2.3593   -2.3189    0.0000 C   0  0
    4.4218   -1.6044    0.0000 O   0  0
    4.8343   -2.3189    0.0000 C   0  0
    3.5968   -0.1755    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  5  9  2  0
  4  6  2  0
 10 11  1  0
 11 12  1  1
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 13 18  1  0
 11 13  1  0
  1 10  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 19 23  1  0
 21 24  1  0
 23 25  1  0
  7 22  1  0
 26 27  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 28 33  2  0
 34 35  1  0
 31 34  1  0
 30 36  1  0
 27 28  1  0
  2 26  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-15826

> <Drug_Names>
SGC-CBP30

> <SYNONYMS>

> <CA_Index_Name>
1H-Benzimidazole, 2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-4-isoxazolyl)-1-[(2S)-2-(4-morpholinyl)propyl]-

> <CAS>
1613695-14-9

> <MWt>
509.03962

> <Formula>
C28H33ClN4O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer; Inflammation/Immunology

> <Target>
Epigenetic Reader Domain; Histone Acetyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 34 37  0  0  0  0            999 V2000
   -2.7186    2.8406    0.0000 C   0  0
   -2.7186    2.0156    0.0000 C   0  0
   -2.0042    1.6031    0.0000 C   0  0
   -1.2897    2.0156    0.0000 C   0  0
   -1.2897    2.8406    0.0000 C   0  0
   -2.0042    3.2531    0.0000 C   0  0
   -0.5752    1.6031    0.0000 C   0  0
   -0.5752    0.7781    0.0000 C   0  0
    0.1392    0.3656    0.0000 C   0  0
    0.8537    0.7781    0.0000 C   0  0
    0.8537    1.6031    0.0000 C   0  0
    0.1392    2.0156    0.0000 C   0  0
    1.4987    0.2637    0.0000 O   0  0
    2.3030    0.4473    0.0000 C   0  0
    2.6610    1.1906    0.0000 C   0  0
    2.3030    1.9339    0.0000 N   0  0
    1.4987    2.1175    0.0000 C   0  0
   -3.4331    3.2531    0.0000 O   0  0
   -4.1476    2.8406    0.0000 C   0  0
   -3.4331    1.6031    0.0000 O   0  0
   -4.1476    2.0156    0.0000 C   0  0
    0.1392   -0.4594    0.0000 O   0  0
    0.8537   -0.8719    0.0000 C   0  0
    0.8537   -1.6969    0.0000 C   0  0  1  0  0  0
    0.1392   -2.1094    0.0000 C   0  0
    0.1392   -2.9344    0.0000 C   0  0
    0.8537   -3.3469    0.0000 C   0  0
    1.5682   -2.9344    0.0000 N   0  0
    1.5682   -2.1094    0.0000 C   0  0
    2.2827   -3.3469    0.0000 C   0  0
    2.8174    2.5789    0.0000 C   0  0
    2.5160    3.3469    0.0000 O   0  0
    3.6332    2.4560    0.0000 C   0  0
    4.1476    3.1010    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 11  1  0
  1 18  1  0
 18 19  1  0
  2 20  1  0
 20 21  1  0
  9 22  1  0
 22 23  1  0
 24 23  1  6
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 24  1  0
 28 30  1  0
 16 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-19541

> <Drug_Names>
I-CBP112

> <SYNONYMS>

> <CA_Index_Name>
1-Propanone, 1-[7-(3,4-dimethoxyphenyl)-2,3-dihydro-9-[[(3S)-1-methyl-3-piperidinyl]methoxy]-1,4-benzoxazepin-4(5H)-yl]-

> <CAS>
1640282-31-0

> <MWt>
468.59

> <Formula>
C27H36N2O5

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Epigenetic Reader Domain; Histone Acetyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 23 25  0  0  0  0            999 V2000
   -2.8554    0.6195    0.0000 N   0  0
   -2.8554   -0.2055    0.0000 N   0  0
   -2.1409   -0.6180    0.0000 C   0  0
   -1.4265   -0.2055    0.0000 C   0  0
   -1.4265    0.6195    0.0000 C   0  0
   -2.1409    1.0320    0.0000 C   0  0
   -0.7145    1.0305    0.0000 Br  0  0
   -0.7145   -0.6166    0.0000 N   0  0
   -0.0025   -0.2055    0.0000 C   0  0  2  0  0  0
    0.7120   -0.6180    0.0000 C   0  0
    1.4265   -0.2055    0.0000 C   0  0  1  0  0  0
    1.4265    0.6195    0.0000 C   0  0
    0.7120    1.0320    0.0000 N   0  0
   -0.0025    0.6195    0.0000 C   0  0
    0.7120    1.8541    0.0000 C   0  0
    2.1385   -0.6166    0.0000 C   0  0
    2.1385   -1.4416    0.0000 C   0  0
    2.8529   -1.8541    0.0000 C   0  0
    3.5674   -1.4416    0.0000 C   0  0
    3.5674   -0.6166    0.0000 C   0  0
    2.8529   -0.2041    0.0000 C   0  0
   -2.1409    1.8541    0.0000 O   0  0
   -3.5674    1.0305    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  1  1  0
  5  7  1  0
  4  8  1  0
  9  8  1  1
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  9  1  0
 13 15  1  0
 11 16  1  1
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
  6 22  2  0
  1 23  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-101027

> <Drug_Names>
GSK 4027

> <SYNONYMS>

> <CA_Index_Name>
3(2H)-Pyridazinone, 4-bromo-2-methyl-5-[[(3R,5R)-1-methyl-5-phenyl-3-piperidinyl]amino]-

> <CAS>
2079896-25-4

> <MWt>
377.28

> <Formula>
C17H21BrN4O

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer; Inflammation/Immunology

> <Target>
Epigenetic Reader Domain; Histone Acetyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 24 27  0  0  0  0            999 V2000
   -3.7985    0.7896    0.0000 C   0  0
   -3.7985   -0.0354    0.0000 C   0  0
   -3.0840   -0.4479    0.0000 C   0  0
   -2.3695   -0.0354    0.0000 C   0  0
   -2.3695    0.7896    0.0000 C   0  0
   -3.0840    1.2021    0.0000 C   0  0
   -1.6551    1.2021    0.0000 C   0  0
   -3.0840    2.0270    0.0000 O   0  0
   -0.9407    0.7896    0.0000 C   0  0
   -1.6551    2.0270    0.0000 O   0  0
   -0.2262    1.2021    0.0000 C   0  0
    0.4883    0.7896    0.0000 N   0  0
    0.2749   -0.0073    0.0000 C   0  0  1  0  0  0
    0.8583   -0.5906    0.0000 C   0  0
    1.6551   -0.3771    0.0000 N   0  0
    1.8686    0.4198    0.0000 C   0  0  1  0  0  0
    1.2853    1.0031    0.0000 C   0  0
    0.9894    0.4052    0.0000 C   0  0
    2.3695   -0.7896    0.0000 C   0  0
    2.3695   -1.6146    0.0000 N   0  0
    3.0840   -2.0270    0.0000 C   0  0
    3.7985   -1.6146    0.0000 C   0  0
    3.7985   -0.7896    0.0000 C   0  0
    3.0840   -0.3771    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  6  8  1  0
  7  9  1  0
  7 10  2  0
  9 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 12  1  0
 13 18  1  1
 16 18  1  1
 15 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-12409

> <Drug_Names>
PFI-3

> <SYNONYMS>

> <CA_Index_Name>
2-Propen-1-one, 1-(2-hydroxyphenyl)-3-[(1R,4R)-5-(2-pyridinyl)-2,5-diazabicyclo[2.2.1]hept-2-yl]-, (2E)-

> <CAS>
1819363-80-8

> <MWt>
321.37

> <Formula>
C19H19N3O2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 27 29  0  0  0  0            999 V2000
    2.1434    1.8563    0.0000 O   0  0
    2.1434    1.0313    0.0000 C   0  0
    2.8579    0.6187    0.0000 O   0  0
    3.5724    1.0313    0.0000 C   0  0
    3.5724    1.8563    0.0000 C   0  0
    4.2868    1.4437    0.0000 C   0  0
    4.2868    0.6187    0.0000 C   0  0
    1.4289    0.6187    0.0000 N   0  0
    1.4289   -0.2062    0.0000 C   0  0
    0.7145   -0.6187    0.0000 C   0  0
    0.0000   -0.2062    0.0000 N   0  0
   -0.7145   -0.6187    0.0000 C   0  0
   -1.4289   -0.2062    0.0000 C   0  0
   -2.1434   -0.6187    0.0000 C   0  0
   -2.1434   -1.4437    0.0000 N   0  0
   -1.4289   -1.8563    0.0000 N   0  0
   -0.7145   -1.4437    0.0000 C   0  0
    0.0000   -1.8563    0.0000 N   0  0
   -2.8579   -0.2062    0.0000 C   0  0
   -3.5724   -0.6187    0.0000 C   0  0
   -4.2868   -0.2062    0.0000 C   0  0
   -4.2868    0.6187    0.0000 C   0  0
   -3.5724    1.0313    0.0000 C   0  0
   -2.8579    0.6187    0.0000 C   0  0
   -2.1434    1.0313    0.0000 O   0  0
    0.0000    0.6187    0.0000 C   0  0
    0.7145    1.0313    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  2  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12 17  2  0
 17 18  1  0
 14 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 19 24  1  0
 24 25  1  0
 11 26  1  0
 26 27  1  0
  8 27  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-145446

> <Drug_Names>
SGC-SMARCA-BRDVIII

> <SYNONYMS>

> <CA_Index_Name>
1-Piperazinecarboxylic acid, 4-[3-amino-6-(2-hydroxyphenyl)-4-pyridazinyl]-, 1,1-dimethylethyl ester

> <CAS>
1997319-84-2

> <MWt>
371.43

> <Formula>
C19H25N5O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Metabolic Disease

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 38 41  0  0  0  0            999 V2000
    1.2160   -0.9693    0.0000 O   0  0
    0.4320   -0.7134    0.0000 C   0  0
   -0.2354   -1.1966    0.0000 C   0  0  2  0  0  0
    0.1761    0.0727    0.0000 N   0  0
   -0.9519   -1.6101    0.0000 C   0  0
    0.4770   -1.6101    0.0000 C   0  0
   -0.9028   -0.7134    0.0000 O   0  0
    0.8905    0.4842    0.0000 C   0  0
   -0.6489    0.0727    0.0000 C   0  0
   -0.9519   -2.4351    0.0000 C   0  0
   -1.6664   -1.1966    0.0000 C   0  0
    0.4770   -2.4351    0.0000 C   0  0
    1.8056   -0.0399    0.0000 C   0  0
   -1.1218    0.7482    0.0000 O   0  0
   -1.6664   -2.8466    0.0000 C   0  0
   -2.3808   -1.6101    0.0000 C   0  0
    2.5201    0.3716    0.0000 N   0  0
    1.8056   -1.0471    0.0000 O   0  0
   -2.3808   -2.4351    0.0000 C   0  0
    2.5201    1.1966    0.0000 C   0  0
    3.2345   -0.0399    0.0000 C   0  0  2  0  0  0
   -3.0953   -2.8466    0.0000 N   0  0
    3.2345    1.6101    0.0000 C   0  0
    3.9490    0.3716    0.0000 C   0  0
    3.2345   -0.8629    0.0000 C   0  0
   -3.8098   -2.4351    0.0000 C   0  0
    3.2345    2.4351    0.0000 C   0  0
    3.9510    1.1966    0.0000 C   0  0
    4.6634   -0.0399    0.0000 F   0  0
    4.3605    1.0881    0.0000 F   0  0
    3.5355    1.0881    0.0000 F   0  0
   -4.5263   -2.8466    0.0000 N   0  0
   -3.8098   -1.6101    0.0000 O   0  0
    3.9510    2.8466    0.0000 C   0  0
    4.6634    1.6101    0.0000 C   0  0
   -5.3779   -2.3553    0.0000 C   0  0
    4.6634    2.4351    0.0000 C   0  0
    5.3779    2.8466    0.0000 F   0  0
  1  2  2  0
  3  2  1  1
  2  4  1  0
  3  5  1  0
  3  6  1  0
  3  7  1  6
  4  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  7  9  1  0
  8 13  1  0
  9 14  2  0
 10 12  1  0
 10 15  2  0
 11 16  1  0
 13 17  1  0
 13 18  2  0
 15 19  1  0
 16 19  2  0
 17 20  1  0
 17 21  1  0
 19 22  1  0
 20 23  1  0
 21 24  1  0
 21 25  1  6
 22 26  1  0
 23 27  2  0
 23 28  1  0
 24 29  1  0
 24 30  1  0
 24 31  1  0
 26 32  1  0
 26 33  2  0
 27 34  1  0
 28 35  2  0
 32 36  1  0
 34 37  2  0
 35 37  1  0
 37 38  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-107455

> <Drug_Names>
A-485

> <SYNONYMS>

> <CA_Index_Name>
Spiro[1H-indene-1,5'-oxazolidine]-3'-acetamide, N-[(4-fluorophenyl)methyl]-2,3-dihydro-5-[[(methylamino)carbonyl]amino]-2',4'-dioxo-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-, (1R)-

> <CAS>
1889279-16-6

> <MWt>
536.48

> <Formula>
C25H24F4N4O5

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Epigenetic Reader Domain; Histone Acetyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 27 29  0  0  0  0            999 V2000
    0.0000   -0.6187    0.0000 C   0  0
    0.7145   -0.2062    0.0000 C   0  0
    0.7145    0.6188    0.0000 C   0  0
    1.4289    1.0313    0.0000 C   0  0
    2.1434    0.6188    0.0000 C   0  0
    2.1434   -0.2062    0.0000 C   0  0
    1.4289   -0.6187    0.0000 C   0  0
    0.0000   -1.4437    0.0000 O   0  0
   -0.7145   -0.2062    0.0000 N   0  0
   -1.4289   -0.6187    0.0000 N   0  0
   -2.1434   -0.2062    0.0000 S   0  0
   -1.7309    0.5082    0.0000 O   0  0
   -2.5559   -0.9207    0.0000 O   0  0
   -2.8579    0.2062    0.0000 C   0  0
   -2.8579    1.0313    0.0000 C   0  0
   -3.5724    1.4438    0.0000 C   0  0
   -4.2868    1.0313    0.0000 C   0  0
   -4.2868    0.2062    0.0000 C   0  0
   -3.5724   -0.2062    0.0000 C   0  0
   -2.1434    1.4438    0.0000 F   0  0
    2.8579   -0.6187    0.0000 C   0  0
    3.5724   -0.2062    0.0000 C   0  0
    4.2868   -0.6187    0.0000 C   0  0
    4.2868   -1.4437    0.0000 C   0  0
    3.5724   -1.8563    0.0000 C   0  0
    2.8579   -1.4437    0.0000 N   0  0
    1.4289    1.8563    0.0000 F   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  2  7  2  0
  1  8  2  0
  9 10  1  0
 11 12  2  0
 11 13  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 14 19  2  0
 15 20  1  0
 11 14  1  0
 10 11  1  0
  1  9  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 21 26  2  0
  6 21  1  0
  4 27  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-102058

> <Drug_Names>
WM-1119

> <SYNONYMS>

> <CA_Index_Name>
Benzoic acid, 3-fluoro-5-(2-pyridinyl)-, 2-[(2-fluorophenyl)sulfonyl]hydrazide

> <CAS>
2055397-28-7

> <MWt>
389.38

> <Formula>
C18H13F2N3O3S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Histone Acetyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 41 45  0  0  0  0            999 V2000
   -1.4809    1.8102    0.0000 C   0  0
   -1.4809    0.9852    0.0000 N   0  0
   -0.7664    0.5727    0.0000 C   0  0
   -0.0519    0.9852    0.0000 C   0  0
   -0.0519    1.8102    0.0000 C   0  0
   -0.7664    2.2227    0.0000 C   0  0  1  0  0  0
    0.7327    0.7303    0.0000 C   0  0
    1.2176    1.3977    0.0000 N   0  0
    0.7327    2.0652    0.0000 N   0  0
    0.9876    2.8498    0.0000 C   0  0
    1.7946    3.0213    0.0000 C   0  0
    2.3466    2.4082    0.0000 C   0  0
    3.1536    2.5797    0.0000 C   0  0
    3.4085    3.3644    0.0000 C   0  0
    2.8565    3.9775    0.0000 C   0  0
    2.0495    3.8059    0.0000 C   0  0
    4.2155    3.5359    0.0000 F   0  0
   -0.7664    3.0477    0.0000 C   0  0
   -0.0519    3.4602    0.0000 O   0  0
   -1.4809    3.4602    0.0000 N   0  0
   -2.1953    0.5727    0.0000 C   0  0
   -2.1953   -0.2523    0.0000 O   0  0
   -2.9098    0.9852    0.0000 C   0  0
   -2.9960    1.8057    0.0000 C   0  0
   -3.8030    1.9772    0.0000 C   0  0
   -4.2155    1.2628    0.0000 C   0  0
   -3.6635    0.6497    0.0000 N   0  0
    0.9876   -0.0543    0.0000 C   0  0
    1.7946   -0.2259    0.0000 O   0  0
    0.4356   -0.6674    0.0000 N   0  0
    0.6905   -1.4521    0.0000 C   0  0
    0.1385   -2.0652    0.0000 C   0  0
    0.3934   -2.8498    0.0000 C   0  0
    1.2004   -3.0213    0.0000 C   0  0
    1.7524   -2.4082    0.0000 C   0  0
    1.4975   -1.6236    0.0000 C   0  0
    2.5594   -2.5797    0.0000 C   0  0
    1.4554   -3.8059    0.0000 O   0  0
    2.2623   -3.9775    0.0000 C   0  0
   -0.1586   -3.4629    0.0000 C   0  0
   -0.0519    2.6352    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 14 17  1  0
  6 18  1  0
 18 19  2  0
 18 20  1  0
  2 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 23  1  0
  7 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 31  1  0
 35 37  1  0
 34 38  1  0
 38 39  1  0
 33 40  1  0
  6 41  1  1
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-19540

> <Drug_Names>
GSK864

> <SYNONYMS>

> <CA_Index_Name>
(S)-1-(4-fluorobenzyl)-N3-(4-methoxy-3,5-dimethylphenyl)-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3,7-dicarboxamide

> <CAS>
1816331-66-4

> <MWt>
558.60

> <Formula>
C30H31FN6O4

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Isocitrate Dehydrogenase (IDH)

> <Pathway>
Metabolic Enzyme/Protease

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 31 34  0  0  0  0            999 V2000
   -1.3386    1.4018    0.0000 C   0  0
    0.0755   -0.2619    0.0000 C   0  0
    0.0755   -1.0869    0.0000 C   0  0
    0.7900   -1.4994    0.0000 N   0  0
    1.5045   -1.0869    0.0000 C   0  0
    1.5045   -0.2619    0.0000 N   0  0
    0.7900    0.1506    0.0000 C   0  0
    0.7900    0.9727    0.0000 N   0  0
    0.0780    1.3838    0.0000 C   0  0
   -0.6340    0.9727    0.0000 C   0  0
    2.2164   -1.4980    0.0000 C   0  0
   -0.6365   -1.4980    0.0000 N   0  0
   -1.3181   -1.0332    0.0000 C   0  0
   -2.1065   -1.2764    0.0000 C   0  0
   -2.4079   -2.0444    0.0000 C   0  0
   -1.9954   -2.7589    0.0000 C   0  0
   -1.1796   -2.8818    0.0000 C   0  0
   -0.5748   -2.3207    0.0000 C   0  0
    2.2164   -2.3230    0.0000 C   0  0
    2.9309   -2.7355    0.0000 C   0  0
    3.6454   -2.3230    0.0000 C   0  0
    3.6454   -1.4980    0.0000 C   0  0
    2.9309   -1.0855    0.0000 N   0  0
   -3.2329   -2.0444    0.0000 C   0  0
   -3.6454   -2.7589    0.0000 C   0  0
   -3.2329   -3.4733    0.0000 C   0  0
   -2.4079   -3.4733    0.0000 C   0  0
   -2.0600    1.0076    0.0000 O   0  0
   -1.3193    2.2237    0.0000 O   0  0
   -2.0214    2.6514    0.0000 C   0  0
   -2.0021    3.4733    0.0000 C   0  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  5 11  1  0
  3 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 12  1  0
 11 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 11  1  0
 15 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 16  1  0
 10  1  1  0
  1 28  2  0
  1 29  1  0
 29 30  1  0
 30 31  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-15648B

> <Drug_Names>
GSK-J4

> <SYNONYMS>

> <CA_Index_Name>
²-Alanine, N-[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-, ethyl ester

> <CAS>
1373423-53-0

> <MWt>
417.50

> <Formula>
C24H27N5O2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Apoptosis; Histone Demethylase

> <Pathway>
Apoptosis; Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 39 44  0  0  0  0            999 V2000
   -1.0076    1.4720    0.0000 C   0  0
   -1.7242    1.8808    0.0000 C   0  0
   -2.4365    1.4645    0.0000 C   0  0
   -2.4322    0.6396    0.0000 C   0  0
   -1.7156    0.2308    0.0000 C   0  0
   -1.0033    0.6470    0.0000 C   0  0
   -1.7285    2.7058    0.0000 N   0  0
   -2.4451    3.1145    0.0000 C   0  0
   -3.1574    2.6983    0.0000 C   0  0
   -3.8740    3.1071    0.0000 C   0  0
   -3.8783    3.9321    0.0000 C   0  0
   -3.1660    4.3483    0.0000 C   0  0
   -2.4494    3.9395    0.0000 C   0  0
   -0.2953    1.8882    0.0000 C   0  0
   -0.2996    2.7132    0.0000 O   0  0
    0.4213    1.4794    0.0000 N   0  0
    1.1337    1.8957    0.0000 C   0  0
    1.8503    1.4869    0.0000 C   0  0
    1.8546    0.6619    0.0000 C   0  0
    1.1423    0.2457    0.0000 C   0  0
    0.4256    0.6544    0.0000 C   0  0
    2.5712    0.2531    0.0000 N   0  0
    3.3231    0.5926    0.0000 C   0  0
    3.8783   -0.0176    0.0000 C   0  0
    3.4695   -0.7342    0.0000 C   0  0
    2.6617   -0.5669    0.0000 C   0  0
   -3.1445    0.2233    0.0000 C   0  0
   -3.8611    0.6321    0.0000 O   0  0
   -3.1402   -0.6016    0.0000 N   0  0
   -3.8525   -1.0179    0.0000 C   0  0
   -3.8482   -1.8429    0.0000 C   0  0
   -3.1316   -2.2516    0.0000 C   0  0
   -2.4193   -1.8354    0.0000 C   0  0
   -2.4236   -1.0104    0.0000 C   0  0
   -3.1273   -3.0766    0.0000 N   0  0
   -3.7922   -3.5650    0.0000 C   0  0
   -3.5332   -4.3483    0.0000 C   0  0
   -2.7082   -4.3440    0.0000 C   0  0
   -2.4574   -3.5581    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
  8 13  2  0
  7  8  1  0
  2  7  1  0
 14 15  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 16 21  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 22 26  1  0
 19 22  1  0
 14 16  1  0
  1 14  1  0
 27 28  2  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 29 34  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 35 39  1  0
 32 35  1  0
 27 29  1  0
  4 27  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-15649

> <Drug_Names>
UNC1215

> <SYNONYMS>

> <CA_Index_Name>
Methanone, 1,1'-[2-(phenylamino)-1,4-phenylene]bis[1-[4-(1-pyrrolidinyl)-1-piperidinyl]-

> <CAS>
1415800-43-9

> <MWt>
529.72

> <Formula>
C32H43N5O2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Apoptosis; Histone Methyltransferase

> <Pathway>
Apoptosis; Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 40 43  0  0  0  0            999 V2000
    4.5585    1.6374    0.0000 C   0  0
    4.5585    0.8096    0.0000 C   0  0
    5.2754    0.3957    0.0000 N   0  0
    5.9923    0.8096    0.0000 C   0  0
    5.9923    1.6374    0.0000 N   0  0
    5.2754    2.0513    0.0000 C   0  0
    3.7712    1.8932    0.0000 C   0  0
    3.2851    1.2235    0.0000 C   0  0
    3.7712    0.5538    0.0000 N   0  0
    5.2754    2.8762    0.0000 N   0  0
    3.5164    2.6777    0.0000 Br  0  0
    2.4303    0.5767    0.0000 O   0  0
    1.8053    0.0340    0.0000 C   0  0  1  0  0  0
    2.1283   -0.7282    0.0000 C   0  0  2  0  0  0
    2.9530   -0.6564    0.0000 C   0  0  2  0  0  0
    3.1396    0.1501    0.0000 C   0  0  2  0  0  0
    1.0016    0.2199    0.0000 C   0  0
    3.4935   -1.2792    0.0000 O   0  0
    1.7031   -1.4350    0.0000 O   0  0
    0.4387   -0.3831    0.0000 N   0  0
   -0.3141   -0.0387    0.0000 C   0  0
    0.4418   -1.2108    0.0000 C   0  0
   -0.3920    0.7825    0.0000 C   0  0
   -0.9863   -0.5167    0.0000 C   0  0
   -0.2703   -1.6272    0.0000 C   0  0
   -0.2658   -2.4521    0.0000 C   0  0
   -0.9780   -2.8685    0.0000 N   0  0
   -1.6946   -2.4599    0.0000 C   0  0
   -2.4067   -2.8762    0.0000 N   0  0
   -1.6991   -1.6349    0.0000 O   0  0
   -3.1233   -2.4676    0.0000 C   0  0
   -3.1302   -1.6399    0.0000 C   0  0
   -3.8500   -1.2319    0.0000 C   0  0
   -4.5635   -1.6399    0.0000 C   0  0
   -4.5635   -2.4676    0.0000 C   0  0
   -3.8500   -2.8757    0.0000 C   0  0
   -5.2770   -1.2259    0.0000 C   0  0
   -5.9923   -1.6369    0.0000 C   0  0
   -5.2753   -0.4011    0.0000 C   0  0
   -4.5618   -0.8149    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  2  0
  8  9  1  0
  9  2  1  0
  6 10  1  0
  7 11  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 12  1  0
 16  9  1  1
 13 17  1  1
 15 18  1  6
 14 19  1  6
 17 20  1  0
 20 21  1  0
 20 22  1  0
 21 23  1  0
 21 24  1  0
 22 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
 29 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 31  1  0
 34 37  1  0
 37 38  1  0
 37 39  1  0
 37 40  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-15650

> <Drug_Names>
SGC0946

> <SYNONYMS>

> <CA_Index_Name>
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 5-bromo-7-[5-deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-²-D-ribofuranosyl]-

> <CAS>
1561178-17-3

> <MWt>
618.57

> <Formula>
C28H40BrN7O4

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 34 38  0  0  0  0            999 V2000
   -1.8984    2.7608    0.0000 C   0  0
   -1.6435    1.9761    0.0000 C   0  0
   -0.8365    1.8046    0.0000 N   0  0
   -0.2844    2.4177    0.0000 C   0  0
   -0.5394    3.2023    0.0000 C   0  0
   -1.3464    3.3739    0.0000 N   0  0
   -1.6004    4.1557    0.0000 S   0  0
   -2.3823    3.9017    0.0000 O   0  0
   -0.8185    4.4098    0.0000 O   0  0
   -1.8545    4.9376    0.0000 C   0  0
   -0.5824    1.0227    0.0000 C   0  0
   -1.1345    0.4096    0.0000 C   0  0
   -0.8795   -0.3750    0.0000 C   0  0
   -0.0725   -0.5465    0.0000 C   0  0
    0.4795    0.0666    0.0000 C   0  0
    0.2245    0.8512    0.0000 C   0  0
    0.1815   -1.3284    0.0000 C   0  0  1  0  0  0
   -0.3034   -1.9959    0.0000 C   0  0
    0.1815   -2.6633    0.0000 N   0  0
    0.9661   -2.4084    0.0000 C   0  0
    0.9661   -1.5834    0.0000 C   0  0  2  0  0  0
    1.6313   -1.1001    0.0000 N   0  0
    2.3823   -1.4345    0.0000 C   0  0
    1.5453   -0.2825    0.0000 C   0  0
   -0.0725   -3.4452    0.0000 C   0  0
   -0.8572   -3.7001    0.0000 C   0  0
   -0.8572   -4.5251    0.0000 C   0  0
   -0.0725   -4.7801    0.0000 C   0  0
    0.4124   -4.1126    0.0000 C   0  0
   -1.5716   -3.2876    0.0000 C   0  0
   -2.2861   -3.7001    0.0000 C   0  0
   -2.2861   -4.5251    0.0000 C   0  0
   -1.5716   -4.9376    0.0000 C   0  0
   -1.5716   -2.4655    0.0000 F   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  1  1  0
  6  7  1  0
  7  8  2  0
  7  9  2  0
  7 10  1  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 17 14  1  6
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 17  1  0
 21 22  1  1
 22 23  1  0
 22 24  1  0
 19 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 25  1  0
 26 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 27  1  0
 30 34  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-101512

> <Drug_Names>
A-395

> <SYNONYMS>

> <CA_Index_Name>
3-Pyrrolidinamine, 1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[4-[4-(methylsulfonyl)-1-piperazinyl]phenyl]-, (3R,4S)-

> <CAS>
2089148-72-9

> <MWt>
486.65

> <Formula>
C26H35FN4O2S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 40 44  0  0  0  0            999 V2000
    3.0764    1.9035    0.0000 N   0  0
    3.5613    1.2362    0.0000 N   0  0
    3.0764    0.5687    0.0000 C   0  0
    2.2918    0.8237    0.0000 C   0  0
    1.5774    0.4112    0.0000 C   0  0
    0.8629    0.8237    0.0000 C   0  0
    0.8629    1.6487    0.0000 C   0  0
    1.5774    2.0611    0.0000 C   0  0
    2.2918    1.6487    0.0000 C   0  0
    1.5774   -0.4138    0.0000 C   0  0
    2.2918   -0.8263    0.0000 O   0  0
    0.8629   -0.8263    0.0000 N   0  0
   -1.2805    2.0611    0.0000 C   0  0
   -0.5660    1.6487    0.0000 C   0  0
    0.1484    2.0611    0.0000 C   0  0
    0.1484    2.8861    0.0000 C   0  0
   -0.5660    3.2986    0.0000 C   0  0
   -1.2805    2.8861    0.0000 N   0  0
   -1.9949    1.6487    0.0000 N   0  0
   -1.9949    0.8237    0.0000 C   0  0
   -2.7093    0.4112    0.0000 C   0  0
   -3.4238    0.8237    0.0000 N   0  0
   -3.4238    1.6487    0.0000 C   0  0
   -2.7093    2.0611    0.0000 C   0  0
   -4.1383    0.4112    0.0000 C   0  0
    0.8629   -1.6513    0.0000 C   0  0
   -0.5660   -1.6513    0.0000 C   0  0
    0.1484   -2.0637    0.0000 C   0  0
    0.1484   -2.8887    0.0000 C   0  0
   -0.5660   -3.3012    0.0000 C   0  0
   -1.2805   -2.8887    0.0000 C   0  0
   -1.2805   -2.0637    0.0000 N   0  0
    0.8629   -3.3012    0.0000 C   0  0
    1.5774   -2.8887    0.0000 C   0  0
    2.2918   -3.3012    0.0000 C   0  0
   -0.5660   -0.8263    0.0000 O   0  0
   -1.9949   -3.3012    0.0000 C   0  0
    3.3313    2.6881    0.0000 C   0  0
    2.7793    3.3012    0.0000 C   0  0
    4.1383    2.8597    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  1  9  1  0
  4  9  2  0
 10 11  2  0
 10 12  1  0
  5 10  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 13 18  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 19 24  1  0
 22 25  1  0
 13 19  1  0
  7 15  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 27 32  1  0
 33 34  1  0
 34 35  1  0
 29 33  1  0
 27 36  2  0
 31 37  1  0
 26 28  1  0
 12 26  1  0
 38 39  1  0
 38 40  1  0
  1 38  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-13500

> <Drug_Names>
GSK343

> <SYNONYMS>

> <CA_Index_Name>
1H-Indazole-4-carboxamide, N-[(1,2-dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-

> <CAS>
1346704-33-3

> <MWt>
541.69

> <Formula>
C31H39N7O2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Autophagy; Histone Methyltransferase

> <Pathway>
Autophagy; Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 42 46  0  0  0  0            999 V2000
   -4.2809    3.9112    0.0000 C   0  0
   -4.2809    3.0861    0.0000 C   0  0
   -3.5665    2.6736    0.0000 C   0  0
   -2.8519    3.0861    0.0000 C   0  0
   -2.8519    3.9112    0.0000 C   0  0
   -3.5665    4.3237    0.0000 N   0  0
   -2.1399    4.3222    0.0000 O   0  0
   -4.9930    4.3222    0.0000 C   0  0
   -3.5665    1.8513    0.0000 C   0  0
   -4.2784    1.4403    0.0000 C   0  0
   -4.2784    0.6180    0.0000 C   0  0
   -2.1399    2.6750    0.0000 C   0  0
   -2.1399    1.8528    0.0000 N   0  0
   -1.4278    1.4417    0.0000 C   0  0
   -1.4278    0.6195    0.0000 C   0  0
   -0.7158    1.8528    0.0000 O   0  0
   -2.1424    0.2070    0.0000 C   0  0
   -2.1424   -0.6180    0.0000 C   0  0
   -1.4278   -1.0306    0.0000 C   0  0
   -0.7133   -0.6180    0.0000 C   0  0
   -0.7133    0.2070    0.0000 C   0  0
   -2.9270    0.4619    0.0000 C   0  0
   -3.4120   -0.2055    0.0000 N   0  0
   -2.9270   -0.8731    0.0000 N   0  0
   -3.1810   -1.6550    0.0000 C   0  0
   -2.6309   -2.2660    0.0000 C   0  0
   -3.9853   -1.8259    0.0000 C   0  0
   -0.0012   -1.0292    0.0000 C   0  0
   -0.0012   -1.8542    0.0000 C   0  0
    0.7133   -2.2668    0.0000 N   0  0
    1.4278   -1.8542    0.0000 C   0  0
    1.4278   -1.0292    0.0000 C   0  0
    0.7133   -0.6166    0.0000 C   0  0
    2.1399   -2.2654    0.0000 N   0  0
    2.1399   -3.0904    0.0000 C   0  0
    2.8544   -3.5030    0.0000 C   0  0
    3.5689   -3.0904    0.0000 N   0  0
    3.5689   -2.2654    0.0000 C   0  0
    2.8544   -1.8528    0.0000 C   0  0
    4.2809   -3.5015    0.0000 C   0  0
    4.9930   -3.0904    0.0000 C   0  0
    4.2809   -4.3237    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  1  1  0
  5  7  2  0
  1  8  1  0
  3  9  1  0
  9 10  1  0
 10 11  1  0
  4 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 15 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 15  1  0
 17 22  1  0
 22 23  2  0
 23 24  1  0
 24 18  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 20 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 31 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 34  1  0
 37 40  1  0
 40 41  1  0
 40 42  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-15646

> <Drug_Names>
UNC1999

> <SYNONYMS>

> <CA_Index_Name>
1H-Indazole-4-carboxamide, N-[(1,2-dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-[4-(1-methylethyl)-1-piperazinyl]-3-pyridinyl]-

> <CAS>
1431612-23-5

> <MWt>
569.74

> <Formula>
C33H43N7O2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Autophagy; Histone Methyltransferase

> <Pathway>
Autophagy; Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 24 27  0  0  0  0            999 V2000
   -4.1978   -1.0633    0.0000 C   0  0
   -3.7888   -1.7798    0.0000 C   0  0
   -2.9810   -1.6121    0.0000 C   0  0
   -2.8974   -0.7914    0.0000 N   0  0
   -3.6535   -0.4518    0.0000 C   0  0
   -2.1829   -0.3789    0.0000 C   0  0
   -1.4685   -0.7914    0.0000 C   0  0
   -0.7540   -0.3789    0.0000 C   0  0
   -0.0395   -0.7914    0.0000 O   0  0
    0.6749   -0.3789    0.0000 C   0  0
    1.3804   -0.8066    0.0000 C   0  0
    2.1036   -0.4095    0.0000 C   0  0
    2.1036    0.4153    0.0000 C   0  0
    1.3804    0.8430    0.0000 C   0  0
    0.6749    0.4459    0.0000 C   0  0
   -0.0395    0.8584    0.0000 O   0  0
   -0.7540    0.4459    0.0000 C   0  0
    2.8880   -0.6644    0.0000 N   0  0
    3.3728    0.0029    0.0000 C   0  0
    2.8880    0.6701    0.0000 C   0  0
    3.6231    1.0447    0.0000 C   0  0
    3.2485    1.7798    0.0000 C   0  0
    2.5135    1.4052    0.0000 C   0  0
    4.1978    0.0029    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 12 18  1  0
 18 19  2  0
 19 20  1  0
 20 13  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 20  1  0
 19 24  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-12583

> <Drug_Names>
A-366

> <SYNONYMS>

> <CA_Index_Name>
Spiro[cyclobutane-1,3'-[3H]indol]-2'-amine, 5'-methoxy-6'-[3-(1-pyrrolidinyl)propoxy]-

> <CAS>
1527503-11-2

> <MWt>
329.44

> <Formula>
C19H27N3O2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Epigenetic Reader Domain; Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 39 43  0  0  0  0            999 V2000
    1.6693    1.7053    0.0000 N   0  0
    2.3838    1.2928    0.0000 C   0  0
    2.3838    0.4678    0.0000 N   0  0
    1.6693    0.0553    0.0000 C   0  0
    0.9548    0.4678    0.0000 C   0  0
    0.2404    0.0553    0.0000 C   0  0
   -0.4741    0.4678    0.0000 C   0  0
   -0.4741    1.2928    0.0000 C   0  0
    0.2404    1.7053    0.0000 C   0  0
    0.9548    1.2928    0.0000 C   0  0
    1.6693   -0.7697    0.0000 N   0  0
   -1.1886    1.7053    0.0000 O   0  0
   -1.9031    1.2928    0.0000 C   0  0
   -2.6175    1.7053    0.0000 C   0  0
   -3.3320    1.2928    0.0000 C   0  0
   -4.0465    1.7053    0.0000 N   0  0
   -4.8004    1.3697    0.0000 C   0  0
   -5.3522    1.9828    0.0000 C   0  0
   -4.9400    2.6973    0.0000 C   0  0
   -4.1327    2.5257    0.0000 C   0  0
   -0.4741   -2.0072    0.0000 N   0  0
   -0.4741   -1.1822    0.0000 C   0  0
    0.2404   -0.7697    0.0000 C   0  0
    0.9548   -1.1822    0.0000 C   0  0
    0.9548   -2.0072    0.0000 C   0  0
    0.2404   -2.4197    0.0000 C   0  0
   -1.1886   -2.4197    0.0000 C   0  0
   -1.1886   -3.2447    0.0000 C   0  0
   -1.9031   -2.0072    0.0000 C   0  0
   -1.1886    0.0553    0.0000 O   0  0
   -1.9031    0.4678    0.0000 C   0  0
    3.0982    1.7053    0.0000 N   0  0
    3.0982    2.5303    0.0000 C   0  0
    3.8127    2.9428    0.0000 C   0  0
    4.5272    2.5303    0.0000 C   0  0
    4.5272    1.7053    0.0000 C   0  0
    3.8127    1.2928    0.0000 C   0  0
    5.3522    2.5303    0.0000 F   0  0
    4.9400    3.2447    0.0000 F   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  1 10  2  0
  5 10  1  0
  4 11  1  0
 13 14  1  0
 14 15  1  0
 12 13  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 16 20  1  0
 15 16  1  0
  8 12  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 21 26  1  0
 27 28  1  0
 27 29  1  0
 21 27  1  0
 11 24  1  0
 30 31  1  0
  7 30  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 32 37  1  0
 35 38  1  0
 35 39  1  0
  2 32  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-13980

> <Drug_Names>
UNC0642

> <SYNONYMS>

> <CA_Index_Name>
4-Quinazolinamine, 2-(4,4-difluoro-1-piperidinyl)-6-methoxy-N-[1-(1-methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)propoxy]-

> <CAS>
1481677-78-4

> <MWt>
546.70

> <Formula>
C29H44F2N6O2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 34 38  0  0  0  0            999 V2000
   -0.6440    2.4849    0.0000 N   0  0
    0.1810    2.4849    0.0000 C   0  0
    0.5935    1.7704    0.0000 C   0  0
    0.1810    1.0560    0.0000 N   0  0
   -0.6440    1.0560    0.0000 C   0  0
   -1.0565    1.7704    0.0000 C   0  0
   -1.4690    1.0560    0.0000 C   0  0
   -2.2940    1.0560    0.0000 C   0  0
   -2.7065    1.7704    0.0000 N   0  0
   -2.2940    2.4849    0.0000 C   0  0
   -1.4690    2.4849    0.0000 C   0  0
   -4.7690    2.4849    0.0000 C   0  0
   -3.9440    2.4849    0.0000 C   0  0
   -3.5315    1.7704    0.0000 C   0  0
   -3.9440    1.0560    0.0000 C   0  0
   -4.7690    1.0560    0.0000 C   0  0
   -5.1815    1.7704    0.0000 N   0  0
   -5.1815    3.1994    0.0000 C   0  0
   -1.0565    3.1994    0.0000 C   0  0
    0.2580   -0.4122    0.0000 O   0  0
    0.8711   -0.9642    0.0000 N   0  0
    1.5856   -0.5517    0.0000 C   0  0
    1.4140    0.2552    0.0000 N   0  0
    0.5935    0.3415    0.0000 C   0  0
    2.3392   -0.8873    0.0000 C   0  0
    2.4255   -1.7078    0.0000 C   0  0
    3.1791   -2.0433    0.0000 C   0  0
    3.8466   -1.5584    0.0000 C   0  0
    3.7603   -0.7379    0.0000 C   0  0
    3.0067   -0.4024    0.0000 C   0  0
    4.4278   -0.2530    0.0000 O   0  0
    5.1815   -0.5886    0.0000 C   0  0
    3.2654   -2.8638    0.0000 O   0  0
    4.0190   -3.1994    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  1  6  1  0
 11  6  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12 17  2  0
 12 18  1  0
  9 14  1  0
  1 19  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 20 24  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 25 30  2  0
 31 32  1  0
 29 31  1  0
 33 34  1  0
 27 33  1  0
 22 25  1  0
  4 24  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-114209

> <Drug_Names>
MRK-740

> <SYNONYMS>

> <CA_Index_Name>
1,4,9-Triazaspiro[5.5]undecane, 4-[3-(3,5-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-methyl-9-(2-methyl-4-pyridinyl)-

> <CAS>
2387510-80-5

> <MWt>
464.56

> <Formula>
C25H32N6O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 21 22  0  0  0  0            999 V2000
   -0.6256   -1.1297    0.0000 C   0  0
   -0.9613   -1.8834    0.0000 C   0  0
   -0.3481   -2.4355    0.0000 N   0  0
    0.3664   -2.0230    0.0000 C   0  0
    0.1949   -1.2159    0.0000 C   0  0
   -1.0368   -0.4176    0.0000 C   0  0
    0.7451   -0.6049    0.0000 C   0  0
    1.5493   -0.7759    0.0000 N   0  0
    1.7620   -1.5700    0.0000 C   0  0
    2.1307   -0.1945    0.0000 C   0  0
    2.9248   -0.4073    0.0000 C   0  0
    3.5063    0.1741    0.0000 N   0  0
   -0.6242    0.2969    0.0000 C   0  0
   -1.0368    1.0114    0.0000 C   0  0
   -1.8618    1.0114    0.0000 C   0  0
   -2.2744    0.2969    0.0000 C   0  0
   -1.8618   -0.4176    0.0000 C   0  0
   -2.2729    1.7234    0.0000 O   0  0
   -3.0951    1.7234    0.0000 C   0  0
   -3.5063    2.4355    0.0000 C   0  0
   -3.5063    1.0114    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  1  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
  6 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  6  1  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-19615

> <Drug_Names>
MS023

> <SYNONYMS>

> <CA_Index_Name>
1,2-Ethanediamine, N1-methyl-N1-[[4-[4-(1-methylethoxy)phenyl]-1H-pyrrol-3-yl]methyl]-

> <CAS>
1831110-54-3

> <MWt>
287.40

> <Formula>
C17H25N3O

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 22 24  0  0  0  0            999 V2000
   -0.6529    0.4125    0.0000 N   0  0
    0.0616    0.0000    0.0000 C   0  0
    0.0616   -0.8250    0.0000 O   0  0
    0.7761    0.4125    0.0000 N   0  0
    1.4906    0.0000    0.0000 C   0  0
    2.2049    0.4125    0.0000 C   0  0
    2.9193    0.0000    0.0000 N   0  0
    3.6730    0.3356    0.0000 C   0  0
    4.2250   -0.2775    0.0000 C   0  0
    3.8125   -0.9920    0.0000 C   0  0
    3.0055   -0.8205    0.0000 C   0  0
    2.2049    1.2375    0.0000 O   0  0
   -2.0817    0.4125    0.0000 C   0  0
   -1.3673    0.0000    0.0000 C   0  0
   -1.3673   -0.8250    0.0000 C   0  0
   -2.0817   -1.2375    0.0000 C   0  0
   -2.7961   -0.8250    0.0000 C   0  0
   -3.5105   -1.2375    0.0000 C   0  0
   -4.2250   -0.8250    0.0000 N   0  0
   -4.2250    0.0000    0.0000 C   0  0
   -3.5105    0.4125    0.0000 C   0  0
   -2.7961    0.0000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  5  6  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  7 11  1  0
  6  7  1  0
  6 12  2  0
  4  5  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 13 22  2  0
 17 22  1  0
  1 14  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-19715

> <Drug_Names>
SGC707

> <SYNONYMS>

> <CA_Index_Name>
Urea, N-6-isoquinolinyl-N'-[2-oxo-2-(1-pyrrolidinyl)ethyl]-

> <CAS>
1687736-54-4

> <MWt>
298.34

> <Formula>
C16H18N4O2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Metabolic Disease

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 34 37  0  0  0  0            999 V2000
   -1.7862    1.0313    0.0000 O   0  0
   -1.7862    0.2062    0.0000 C   0  0
   -1.0717   -0.2062    0.0000 N   0  0
   -1.0717   -1.0313    0.0000 C   0  0
   -0.3572    0.2062    0.0000 C   0  0
    0.3572   -0.2062    0.0000 C   0  0
    1.0717    0.2062    0.0000 C   0  0
    1.7862   -0.2062    0.0000 C   0  0
    2.5006    0.2062    0.0000 C   0  0
    2.5006    1.0313    0.0000 C   0  0
    3.2151    1.4437    0.0000 C   0  0
    3.9296    1.0313    0.0000 N   0  0
    4.6441    1.4437    0.0000 C   0  0
    5.3585    1.0313    0.0000 C   0  0
    6.0730    1.4437    0.0000 N   0  0
    6.7875    1.0313    0.0000 C   0  0
    3.9296    0.2062    0.0000 C   0  0
    3.2151   -0.2062    0.0000 C   0  0
    1.7862   -1.0313    0.0000 N   0  0
    1.0717   -1.4437    0.0000 C   0  0
    0.3572   -1.0313    0.0000 C   0  0
   -2.5006   -0.2062    0.0000 C   0  0
   -2.5006   -1.0313    0.0000 C   0  0
   -3.2151   -1.4437    0.0000 C   0  0
   -3.9296   -1.0313    0.0000 C   0  0
   -3.9296   -0.2062    0.0000 C   0  0
   -4.6441    0.2062    0.0000 O   0  0
   -5.3585   -0.2062    0.0000 C   0  0
   -5.3585   -1.0313    0.0000 C   0  0
   -6.0730   -1.4437    0.0000 C   0  0
   -6.7875   -1.0313    0.0000 C   0  0
   -6.7875   -0.2062    0.0000 C   0  0
   -6.0730    0.2062    0.0000 C   0  0
   -3.2151    0.2062    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 12 17  1  0
 17 18  1  0
  9 18  1  0
  8 19  2  0
 19 20  1  0
 20 21  2  0
  6 21  1  0
  2 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 28 33  1  0
 26 34  2  0
 22 34  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-114965

> <Drug_Names>
TP-064

> <SYNONYMS>

> <CA_Index_Name>
Benzamide, N-methyl-N-[[2-[1-[2-(methylamino)ethyl]-4-piperidinyl]-4-pyridinyl]methyl]-3-phenoxy-

> <CAS>
2080306-20-1

> <MWt>
458.60

> <Formula>
C28H34N4O2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer; Inflammation/Immunology

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 28 31  0  0  0  0            999 V2000
   -3.0671    0.0000    0.0000 C   0  0
   -2.3527    0.4125    0.0000 C   0  0
   -1.6382    0.0000    0.0000 C   0  0
   -1.6382   -0.8250    0.0000 C   0  0
   -2.3527   -1.2375    0.0000 C   0  0
   -3.0671   -0.8250    0.0000 N   0  0
   -0.9237    0.4125    0.0000 C   0  0
   -0.9237    1.2375    0.0000 O   0  0
   -0.2093    0.0000    0.0000 N   0  0
    0.5052    0.4125    0.0000 C   0  0
    1.2197    0.0000    0.0000 C   0  0  1  0  0  0
    1.9341    0.4125    0.0000 C   0  0
    1.2197   -0.8250    0.0000 O   0  0
    3.3631    0.4125    0.0000 C   0  0
    2.6486    0.0000    0.0000 N   0  0
    2.6486   -0.8250    0.0000 C   0  0
    3.3631   -1.2375    0.0000 C   0  0
    4.0776   -0.8250    0.0000 C   0  0
    4.7920   -1.2375    0.0000 C   0  0
    5.5065   -0.8250    0.0000 C   0  0
    5.5065    0.0000    0.0000 C   0  0
    4.7920    0.4125    0.0000 C   0  0
    4.0776    0.0000    0.0000 C   0  0
   -3.7816    0.4125    0.0000 N   0  0
   -4.4961    0.0000    0.0000 C   0  0
   -4.7096   -0.7969    0.0000 C   0  0
   -5.5065   -0.5834    0.0000 C   0  0
   -5.2930    0.2135    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  2  0
  7  8  2  0
  7  9  1  0
  3  7  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  1
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 14 23  1  0
 18 23  2  0
 12 15  1  0
  9 10  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 25 28  1  0
 24 25  1  0
  1 24  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-100235

> <Drug_Names>
GSK591

> <SYNONYMS>
EPZ015866; GSK3203591

> <CA_Index_Name>
4-Pyridinecarboxamide, 2-(cyclobutylamino)-N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-

> <CAS>
1616391-87-7

> <MWt>
380.48

> <Formula>
C22H28N4O2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 26 29  0  0  0  0            999 V2000
   -0.5576   -1.9535    0.0000 O   0  0
   -0.0726   -1.2829    0.0000 C   0  0  1  0  0  0
   -0.3100   -0.5176    0.0000 C   0  0  2  0  0  0
   -1.0261   -0.1028    0.0000 N   0  0
   -2.4542   -0.1028    0.0000 C   0  0
   -2.4542    0.7207    0.0000 C   0  0
   -1.7381    1.1375    0.0000 C   0  0
   -1.0261    0.7207    0.0000 C   0  0
   -3.1661    1.1375    0.0000 C   0  0
   -3.1661    1.9611    0.0000 N   0  0
   -3.8822    0.7207    0.0000 N   0  0
   -3.8822   -0.1028    0.0000 C   0  0
   -3.1661   -0.5176    0.0000 N   0  0
    0.3712   -0.0117    0.0000 O   0  0
    1.0240   -0.5176    0.0000 C   0  0  1  0  0  0
    0.7579   -1.2829    0.0000 C   0  0  1  0  0  0
    1.2306   -1.9611    0.0000 O   0  0
    1.7381   -0.1028    0.0000 C   0  0  2  0  0  0
    1.7381    0.7207    0.0000 O   0  0
    2.4542   -0.5176    0.0000 C   0  0
    2.4542   -1.3412    0.0000 C   0  0
    3.1682   -1.7500    0.0000 C   0  0
    3.8822   -1.3412    0.0000 C   0  0
    3.8822   -0.5176    0.0000 C   0  0
    3.1682   -0.1028    0.0000 C   0  0
    1.6562   -1.0466    0.0000 H   0  0
  2  1  1  1
  2  3  1  0
  2 16  1  0
  3  4  1  6
  3 14  1  0
  4  5  1  0
  4  8  1  0
  5  6  1  0
  5 13  2  0
  6  7  1  0
  6  9  2  0
  8  7  2  0
  9 10  1  0
  9 11  1  0
 12 11  2  0
 13 12  1  0
 14 15  1  0
 16 15  1  0
 15 18  1  0
 15 26  1  1
 16 17  1  1
 18 19  1  6
 18 20  1  0
 20 21  2  0
 20 25  1  0
 21 22  1  0
 22 23  2  0
 24 23  1  0
 25 24  2  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-107777

> <Drug_Names>
LLY-283

> <SYNONYMS>

> <CA_Index_Name>
(2R,3R,4S,5R)-2-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-((R)-hydroxy(phenyl)methyl)tetrahydrofuran-3,4-diol

> <CAS>
2040291-27-6

> <MWt>
342.35

> <Formula>
C17H18N4O4

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 36 38  0  0  0  0            999 V2000
    2.8578    0.9913    0.0000 C   0  0
    3.5723    0.5788    0.0000 N   0  0
    3.5723   -0.2462    0.0000 C   0  0
    2.8578   -0.6587    0.0000 C   0  0
    2.1433   -0.2462    0.0000 C   0  0
    1.4289   -0.6587    0.0000 C   0  0
    0.7145   -0.2462    0.0000 C   0  0
    0.7145    0.5788    0.0000 C   0  0
    1.4289    0.9913    0.0000 C   0  0
    2.1433    0.5788    0.0000 C   0  0
    0.0000   -0.6587    0.0000 S   0  0
   -0.4125    0.0558    0.0000 O   0  0
    0.4125   -1.3732    0.0000 O   0  0
   -0.7145   -1.0712    0.0000 N   0  0
   -1.4289   -0.6587    0.0000 C   0  0  1  0  0  0
   -2.1433   -1.0712    0.0000 C   0  0
   -1.4289    0.1663    0.0000 C   0  0
   -2.1433    0.5788    0.0000 C   0  0
   -2.1433    1.4038    0.0000 C   0  0
   -2.8578    1.8162    0.0000 C   0  0
   -3.5723    1.4038    0.0000 C   0  0
   -3.5723    0.5788    0.0000 C   0  0
   -2.8578    0.1663    0.0000 C   0  0
   -2.8578    2.6412    0.0000 C   0  0
   -2.8578    3.4662    0.0000 F   0  0
   -2.1433    3.0537    0.0000 F   0  0
   -3.5723    3.0537    0.0000 F   0  0
   -2.1433   -1.8962    0.0000 N   0  0
   -1.4760   -2.3810    0.0000 C   0  0
   -1.7309   -3.1656    0.0000 C   0  0
   -2.5558   -3.1656    0.0000 C   0  0
   -2.8108   -2.3810    0.0000 C   0  0
   -2.8578   -0.6587    0.0000 O   0  0
    1.4289    1.8162    0.0000 F   0  0
   -0.0020   -3.4662    0.0000 H   0  0
    0.8229   -3.4615    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  1 10  1  0
  5 10  2  0
 11 12  2  0
 11 13  2  0
 11 14  1  0
  7 11  1  0
 15 16  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 18 23  2  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
 20 24  1  0
 17 18  1  0
 15 17  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 28 32  1  0
 16 28  1  0
 16 33  2  0
 15 14  1  1
  9 34  1  0
 35 36  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-18627A

> <Drug_Names>
PFI-2 (hydrochloride)

> <SYNONYMS>
(R)-PFI-2 hydrochloride

> <CA_Index_Name>
6-Isoquinolinesulfonamide, 8-fluoro-1,2,3,4-tetrahydro-N-[(1R)-2-oxo-2-(1-pyrrolidinyl)-1-[[3-(trifluoromethyl)phenyl]methyl]ethyl]-, hydrochloride (1:1)

> <CAS>
1627607-87-7

> <MWt>
535.98

> <Formula>
C23H26ClF4N3O3S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer; Infection; Inflammation/Immunology

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 35 37  0  0  0  0            999 V2000
   -3.6843   -1.3928    0.0000 C   0  0
   -3.5127   -2.1998    0.0000 C   0  0
   -2.7281   -2.4547    0.0000 C   0  0
   -2.1150   -1.9027    0.0000 C   0  0
   -2.2866   -1.0957    0.0000 C   0  0
   -3.0712   -0.8408    0.0000 C   0  0
   -4.4689   -1.1379    0.0000 Cl  0  0
   -4.1258   -2.7518    0.0000 Cl  0  0
   -1.6735   -0.5437    0.0000 C   0  0
   -0.8665   -0.7152    0.0000 N   0  0
   -0.4540   -0.0007    0.0000 N   0  0
   -1.0060    0.6124    0.0000 C   0  0
   -1.7597    0.2768    0.0000 C   0  0  2  0  0  0
    0.3665    0.0855    0.0000 C   0  0
    0.7020    0.8392    0.0000 N   0  0
    0.8514   -0.5819    0.0000 N   0  0
    1.6719   -0.4957    0.0000 C   0  0
    2.1568   -1.1631    0.0000 C   0  0
    2.9773   -1.0769    0.0000 C   0  0
    3.3129   -0.3232    0.0000 C   0  0
    2.8279    0.3442    0.0000 C   0  0
    2.0075    0.2580    0.0000 C   0  0
    3.1635    1.0979    0.0000 O   0  0
    3.9840    1.1841    0.0000 C   0  0
    4.3195    1.9378    0.0000 F   0  0
    4.4689    0.5167    0.0000 F   0  0
   -2.4742    0.6893    0.0000 N   0  0
   -3.1886    0.2768    0.0000 C   0  0
   -3.9031    0.6893    0.0000 C   0  0
   -2.4742    1.5143    0.0000 C   0  0
   -3.1886    1.9268    0.0000 C   0  0
   -1.7597    1.9268    0.0000 O   0  0
   -3.1886    2.7518    0.0000 O   0  0
    0.2171    1.5066    0.0000 C   0  0
   -0.2661    2.1717    0.0000 N   0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  2  8  1  0
  5  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  9  1  0
 11 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 13 27  1  1
 27 28  1  0
 28 29  1  0
 27 30  1  0
 30 31  1  0
 30 32  2  0
 31 33  1  0
 15 34  1  0
 34 35  3  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-19546

> <Drug_Names>
BAY-598

> <SYNONYMS>

> <CA_Index_Name>
Acetamide, N-[(4S)-1-[(cyanoamino)[[3-(difluoromethoxy)phenyl]imino]methyl]-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxy-

> <CAS>
1906919-67-2

> <MWt>
525.34

> <Formula>
C22H20Cl2F2N6O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 29 33  0  0  0  0            999 V2000
   -0.3396    1.4084    0.0000 C   0  0
   -0.3396    0.5834    0.0000 C   0  0
    0.3749    0.1709    0.0000 C   0  0
    1.0894    0.5834    0.0000 C   0  0
    1.0894    1.4084    0.0000 C   0  0
    0.3749    1.8209    0.0000 C   0  0
    1.7344    0.0690    0.0000 N   0  0
    2.5387    0.2526    0.0000 C   0  0  2  0  0  0
    2.8967    0.9959    0.0000 C   0  0
    2.5387    1.7392    0.0000 C   0  0
    1.7344    1.9228    0.0000 N   0  0
    3.0531    2.3842    0.0000 O   0  0
   -1.0540    1.8209    0.0000 C   0  0
   -1.7685    1.4084    0.0000 N   0  0
   -1.0540    2.6459    0.0000 O   0  0
   -2.4830    1.8209    0.0000 C   0  0
   -3.1975    1.4084    0.0000 C   0  0
   -3.1975    0.5834    0.0000 C   0  0
   -3.6100   -0.1311    0.0000 C   0  0
   -2.7850   -0.1311    0.0000 C   0  0
    1.5508   -0.7353    0.0000 C   0  0
    2.1556   -1.2964    0.0000 N   0  0
    0.7625   -0.9785    0.0000 O   0  0
    2.0571   -2.1155    0.0000 C   0  0
    2.8056   -2.4623    0.0000 C   0  0
    3.3668   -1.8576    0.0000 C   0  0
    2.9650   -1.1370    0.0000 C   0  0
    3.6100   -2.6459    0.0000 C   0  0
    3.0531   -0.3924    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  5  1  0
 10 12  2  0
  1 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 18  1  0
  7 21  1  0
 21 22  1  0
 21 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 22  1  0
 25 28  1  0
 28 26  1  0
  8 29  1  6
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-112080

> <Drug_Names>
BAY-6035

> <SYNONYMS>

> <CA_Index_Name>
1H-1,5-Benzodiazepine-7-carboxamide, 1-(3-azabicyclo[3.1.0]hex-3-ylcarbonyl)-N-(2-cyclopropylethyl)-2,3,4,5-tetrahydro-2-methyl-4-oxo-, (2S)-

> <CAS>
2247890-13-5

> <MWt>
396.48

> <Formula>
C22H28N4O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 24 27  0  0  0  0            999 V2000
   -1.7246    0.5352    0.0000 C   0  0
   -1.7246   -0.2898    0.0000 C   0  0
   -1.0101   -0.7023    0.0000 C   0  0
   -0.2956   -0.2898    0.0000 C   0  0
   -0.2956    0.5352    0.0000 C   0  0
   -1.0101    0.9477    0.0000 C   0  0
    0.4189   -0.7023    0.0000 C   0  0
    1.1333   -0.2898    0.0000 N   0  0
    1.1333    0.5352    0.0000 N   0  0
    0.4189    0.9477    0.0000 C   0  0
    0.4189    1.7727    0.0000 N   0  0
    1.1333    2.1852    0.0000 C   0  0
    1.8870    1.8497    0.0000 C   0  0
    2.4390    2.4628    0.0000 C   0  0
    2.0265    3.1773    0.0000 C   0  0
    1.2196    3.0057    0.0000 C   0  0
   -2.4390    0.9477    0.0000 Cl  0  0
   -2.4390   -0.7023    0.0000 Cl  0  0
    0.4189   -1.5273    0.0000 C   0  0
   -0.2956   -1.9398    0.0000 C   0  0
   -0.2956   -2.7648    0.0000 C   0  0
    0.4189   -3.1773    0.0000 N   0  0
    1.1333   -2.7648    0.0000 C   0  0
    1.1333   -1.9398    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 12  1  0
  1 17  1  0
  2 18  1  0
  7 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-100201

> <Drug_Names>
A-196

> <SYNONYMS>

> <CA_Index_Name>
6,7-dichloro-N-cyclopentyl-4-(pyridin-4-yl)phthalazin-1-amine

> <CAS>
1982372-88-2

> <MWt>
359.25

> <Formula>
C18H16Cl2N4

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 37 41  0  0  0  0            999 V2000
   -2.0393   -0.1762    0.0000 C   0  0
   -2.0393   -1.0012    0.0000 O   0  0
    1.3737    0.6488    0.0000 C   0  0
    0.8888   -0.0187    0.0000 N   0  0
    0.1041    0.2363    0.0000 C   0  0
    0.1041    1.0613    0.0000 C   0  0
    0.8888    1.3162    0.0000 N   0  0
   -0.6103   -0.1762    0.0000 C   0  0
   -1.3248    0.2363    0.0000 C   0  0
   -1.3248    1.0613    0.0000 C   0  0
   -0.6103    1.4738    0.0000 C   0  0
    1.1437    2.1008    0.0000 C   0  0
   -0.6103    2.2988    0.0000 O   0  0
   -1.3248    2.7113    0.0000 C   0  0
    2.6836   -0.0187    0.0000 N   0  0
    2.1987    0.6488    0.0000 C   0  0
    2.6836    1.3162    0.0000 C   0  0
    3.4682    1.0613    0.0000 C   0  0
    4.1827    1.4738    0.0000 C   0  0
    4.8972    1.0613    0.0000 C   0  0
    4.8972    0.2363    0.0000 C   0  0
    4.1827   -0.1762    0.0000 C   0  0
    3.4682    0.2363    0.0000 C   0  0
    2.4287   -0.8033    0.0000 C   0  0
    1.6217   -0.9748    0.0000 C   0  0
    1.0086   -1.5269    0.0000 C   0  0
    0.8371   -0.7199    0.0000 C   0  0
   -2.7538    0.2363    0.0000 N   0  0
   -3.4682   -0.1762    0.0000 C   0  0
   -4.1827    0.2363    0.0000 C   0  0  1  0  0  0
   -4.1827    1.0613    0.0000 C   0  0  1  0  0  0
   -3.4682    1.4738    0.0000 C   0  0
   -2.7538    1.0613    0.0000 C   0  0
   -4.8972    1.4738    0.0000 O   0  0
   -4.8972   -0.1762    0.0000 N   0  0
   -1.2566   -2.7113    0.0000 H   0  0
   -0.4316   -2.7113    0.0000 Cl  0  0
  1  2  2  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  3  7  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  6 11  2  0
  5  8  2  0
  7 12  1  0
 13 14  1  0
 11 13  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 15 23  1  0
 18 23  2  0
 25 26  1  0
 26 27  1  0
 25 27  1  0
 24 25  1  0
 15 24  1  0
  3 16  1  0
  1  9  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 28 33  1  0
 31 34  1  6
 30 35  1  6
  1 28  1  0
 36 37  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-100514

> <Drug_Names>
GSK484 (hydrochloride)

> <SYNONYMS>

> <CA_Index_Name>
Methanone, [(3S,4R)-3-amino-4-hydroxy-1-piperidinyl][2-[1-(cyclopropylmethyl)-1H-indol-2-yl]-7-methoxy-1-methyl-1H-benzimidazol-5-yl]-, hydrochloride (1:1)

> <CAS>
1652591-81-5

> <MWt>
510.03

> <Formula>
C27H32ClN5O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer; Inflammation/Immunology; Cardiovascular Disease

> <Target>
Protein Arginine Deiminase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 33 37  0  0  0  0            999 V2000
   -2.8578   -1.4437    0.0000 O   0  0
   -2.8578   -0.6187    0.0000 C   0  0
   -3.5723   -0.2062    0.0000 N   0  0
   -4.2867   -0.6187    0.0000 C   0  0
   -4.2867   -1.4437    0.0000 N   0  0
   -5.0011   -1.8562    0.0000 C   0  0
   -5.7156   -1.4437    0.0000 N   0  0
   -5.7156   -0.6187    0.0000 C   0  0
   -5.0011   -0.2062    0.0000 C   0  0
   -2.1433   -0.2062    0.0000 C   0  0
   -2.1433    0.6187    0.0000 C   0  0
   -1.4289    1.0313    0.0000 C   0  0
   -0.7145    0.6187    0.0000 C   0  0
   -0.7145   -0.2062    0.0000 C   0  0
   -1.4289   -0.6187    0.0000 C   0  0
    0.0000    1.0313    0.0000 C   0  0
    0.7145    0.6187    0.0000 N   0  0
    1.4289    1.0313    0.0000 C   0  0
    1.4289    1.8562    0.0000 O   0  0
    2.1433    0.6187    0.0000 C   0  0
    2.1433   -0.2062    0.0000 C   0  0
    2.8578   -0.6187    0.0000 C   0  0
    3.5723   -0.2062    0.0000 C   0  0
    4.2867   -0.6187    0.0000 N   0  0
    5.0011   -0.2062    0.0000 C   0  0
    5.7156   -0.6187    0.0000 O   0  0
    5.0011    0.6187    0.0000 C   0  0
    4.2867    1.0313    0.0000 O   0  0
    3.5723    0.6187    0.0000 C   0  0
    2.8578    1.0313    0.0000 C   0  0
    0.7145   -0.2062    0.0000 C   0  0
    1.1270   -0.9207    0.0000 C   0  0
    0.3020   -0.9207    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  4  9  2  0
  2 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 10 15  1  0
 13 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 23 29  1  0
 29 30  2  0
 20 30  1  0
 17 31  1  0
 31 32  1  0
 32 33  1  0
 31 33  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-145103

> <Drug_Names>
UNC6934

> <SYNONYMS>

> <CA_Index_Name>
2H-1,4-Benzoxazine-7-carboxamide, N-cyclopropyl-3,4-dihydro-3-oxo-N-[[4-[(4-pyrimidinylamino)carbonyl]phenyl]methyl]-

> <CAS>
2561494-77-5

> <MWt>
443.45

> <Formula>
C24H21N5O4

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Histone Methyltransferase

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 40 44  0  0  0  0            999 V2000
   -2.8579    3.3000    0.0000 C   0  0
   -2.8579    2.4750    0.0000 C   0  0
   -2.1434    2.0625    0.0000 C   0  0
   -1.4289    2.4750    0.0000 C   0  0
   -1.4289    3.3000    0.0000 C   0  0
   -2.1434    3.7125    0.0000 C   0  0
   -0.7145    3.7125    0.0000 C   0  0
    0.0000    3.3000    0.0000 N   0  0
    0.0000    2.4750    0.0000 C   0  0
    0.7145    2.0625    0.0000 C   0  0
    1.4289    2.4750    0.0000 O   0  0
    1.4289    3.3000    0.0000 C   0  0
    0.7145    3.7125    0.0000 C   0  0
   -2.1434    1.2375    0.0000 C   0  0
   -2.8579    0.8250    0.0000 C   0  0
   -2.8579    0.0000    0.0000 C   0  0
   -2.1434   -0.4125    0.0000 C   0  0
   -1.4289    0.0000    0.0000 C   0  0
   -1.4289    0.8250    0.0000 C   0  0
   -2.1434   -1.2375    0.0000 N   0  0
   -2.8579   -1.6500    0.0000 C   0  0
   -2.8579   -2.4750    0.0000 C   0  0
   -2.1434   -2.8875    0.0000 N   0  0
   -1.4289   -2.4750    0.0000 C   0  0
   -1.4289   -1.6500    0.0000 C   0  0
   -0.7145   -0.4125    0.0000 N   0  0
    0.0000    0.0000    0.0000 C   0  0
    0.7145   -0.4125    0.0000 C   0  0
    0.0000    0.8250    0.0000 O   0  0
    0.7145   -1.2375    0.0000 C   0  0
    1.4289   -1.6500    0.0000 N   0  0
    2.1434   -1.2375    0.0000 C   0  0
    2.1434   -0.4125    0.0000 C   0  0
    1.4289    0.0000    0.0000 C   0  0
   -2.1434   -3.7125    0.0000 C   0  0
    2.8579   -1.6500    0.0000 O   0  0
    1.4289    0.8250    0.0000 C   0  0
    2.1434    1.2375    0.0000 F   0  0
    1.4289    1.6500    0.0000 F   0  0
    0.7145    1.2375    0.0000 F   0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  8  1  0
  3 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 20  1  0
 18 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
 28 30  2  0
 30 31  1  0
 32 33  1  0
 33 34  2  0
 34 28  1  0
 23 35  1  0
 32 31  1  0
 32 36  2  0
 34 37  1  0
 37 38  1  0
 37 39  1  0
 37 40  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-16993

> <Drug_Names>
OICR-9429

> <SYNONYMS>

> <CA_Index_Name>
3-Pyridinecarboxamide, 1,6-dihydro-N-[4-(4-methyl-1-piperazinyl)-3'-(4-morpholinylmethyl)[1,1'-biphenyl]-3-yl]-6-oxo-4-(trifluoromethyl)-

> <CAS>
1801787-56-3

> <MWt>
555.59

> <Formula>
C29H32F3N5O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Apoptosis; Histone Methyltransferase

> <Pathway>
Apoptosis; Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 35 37  0  0  0  0            999 V2000
   -0.8813    1.1856    0.0000 N   0  0
   -0.0535    1.1856    0.0000 N   0  0
   -1.1370    0.3983    0.0000 C   0  0
   -0.4674   -0.0882    0.0000 S   0  0
    0.2023    0.3983    0.0000 C   0  0
   -1.9216    0.1434    0.0000 C   0  0
   -2.5346    0.6954    0.0000 C   0  0
   -2.3626    1.5051    0.0000 C   0  0
   -2.9777    2.0590    0.0000 C   0  0
   -3.7650    1.8032    0.0000 C   0  0
   -3.9371    0.9935    0.0000 C   0  0
   -3.3219    0.4396    0.0000 C   0  0
   -4.3781    2.3551    0.0000 C   0  0
    0.9868    0.1434    0.0000 N   0  0
    1.5999    0.6954    0.0000 C   0  0
    1.4284    1.5023    0.0000 O   0  0
    2.3844    0.4405    0.0000 C   0  0  2  0  0  0
    2.5559   -0.3664    0.0000 N   0  0
    2.9975    0.9924    0.0000 C   0  0
    2.8259    1.7994    0.0000 C   0  0
    2.0414    2.0542    0.0000 C   0  0
    3.4390    2.3513    0.0000 C   0  0
    3.3405   -0.6213    0.0000 C   0  0
    3.9535   -0.0693    0.0000 O   0  0
    3.5120   -1.4282    0.0000 C   0  0
    2.6856   -1.4756    0.0000 C   0  0
    2.3134   -2.2151    0.0000 C   0  0
    2.7676   -2.9070    0.0000 C   0  0
    3.5941   -2.8596    0.0000 C   0  0
    3.9663   -2.1203    0.0000 C   0  0
    4.2733   -1.1106    0.0000 C   0  0
    4.3790   -0.2925    0.0000 F   0  0
    4.9290   -1.6112    0.0000 F   0  0
    4.9902   -0.6968    0.0000 F   0  0
   -4.9902    2.9070    0.0000 N   0  0
  1  2  1  0
  1  3  2  0
  3  4  1  0
  4  5  1  0
  5  2  2  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 10 13  1  0
  5 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 17 19  1  1
 19 20  1  0
 20 21  1  0
 20 22  1  0
 18 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 25  1  0
 25 31  1  0
 31 32  1  0
 31 33  1  0
 31 34  1  0
 13 35  3  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-153045

> <Drug_Names>
BAY-805

> <SYNONYMS>

> <CA_Index_Name>
Cyclohexanecarboxamide, N-[(1R)-1-[[[5-[(4-cyanophenyl)methyl]-1,3,4-thiadiazol-2-yl]amino]carbonyl]-3-methylbutyl]-1-(trifluoromethyl)-

> <CAS>
2925481-88-3

> <MWt>
507.57

> <Formula>
C24H28F3N5O2S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Deubiquitinase

> <Pathway>
Cell Cycle/DNA Damage

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 25 27  0  0  0  0            999 V2000
    5.4689    1.8734    0.0000 N   0  0
    4.8014    1.3885    0.0000 C   0  0
    4.1340    0.9036    0.0000 N   0  0
    4.1340    0.0786    0.0000 C   0  0
    3.3494   -0.1764    0.0000 C   0  0
    2.8645    0.4911    0.0000 C   0  0  2  0  0  0
    2.0395    0.4911    0.0000 C   0  0
    1.6270    1.2055    0.0000 O   0  0
    1.6270   -0.2234    0.0000 N   0  0
    0.8020   -0.2234    0.0000 C   0  0
    0.3170    0.4440    0.0000 N   0  0
   -0.4676    0.1891    0.0000 C   0  0
   -0.4676   -0.6359    0.0000 C   0  0
   -1.1821   -1.0484    0.0000 C   0  0
   -1.8965   -0.6359    0.0000 N   0  0
   -2.6110   -1.0484    0.0000 C   0  0
   -2.6110   -1.8734    0.0000 O   0  0
   -3.3255   -0.6359    0.0000 C   0  0
   -4.0399   -1.0484    0.0000 N   0  0
   -4.7544   -0.6359    0.0000 N   0  3
   -5.4689   -0.2234    0.0000 N   0  5
   -1.8965    0.1891    0.0000 C   0  0
   -1.1821    0.6016    0.0000 C   0  0
    0.3170   -0.8908    0.0000 S   0  0
    3.3494    1.1585    0.0000 C   0  0
  1  2  3  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  6
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  2  0
 15 22  1  0
 22 23  1  0
 12 23  1  0
 13 24  1  0
 10 24  1  0
  6 25  1  0
  3 25  1  0
M  CHG  2  20   1  21  -1
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-148254

> <Drug_Names>
8RK64

> <SYNONYMS>

> <CA_Index_Name>
3-Pyrrolidinecarboxamide, N-[5-(2-azidoacetyl)-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl]-1-cyano-, (3S)-

> <CAS>
2705841-52-5

> <MWt>
360.39

> <Formula>
C14H16N8O2S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Deubiquitinase

> <Pathway>
Cell Cycle/DNA Damage

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 27 30  0  0  0  0            999 V2000
   -2.4982    1.8179    0.0000 C   0  0
   -2.4982    0.9928    0.0000 C   0  0
   -1.7837    0.5803    0.0000 C   0  0
   -1.0692    0.9928    0.0000 C   0  0
   -1.0692    1.8179    0.0000 C   0  0
   -1.7837    2.2304    0.0000 C   0  0
   -0.3548    0.5803    0.0000 C   0  0
    0.3597    0.9928    0.0000 N   0  0
    0.3597    1.8179    0.0000 N   0  0
   -0.3548    2.2304    0.0000 C   0  0
    0.9728    2.3699    0.0000 C   0  0
    0.6373    3.1236    0.0000 N   0  0
   -0.1832    3.0373    0.0000 N   0  0
   -0.3548   -0.2418    0.0000 N   0  0
    0.3572   -0.6529    0.0000 C   0  0  2  0  0  0
    0.3572   -1.4750    0.0000 C   0  0  1  0  0  0
    1.0692   -0.2418    0.0000 C   0  0
   -0.3548   -1.8861    0.0000 N   0  0
    1.0692   -1.8861    0.0000 C   0  0
   -0.3548   -2.7082    0.0000 C   0  0
   -1.0667   -1.4750    0.0000 C   0  0
    1.0692   -2.7111    0.0000 C   0  0
    1.7837   -3.1236    0.0000 C   0  0
    2.4982   -2.7111    0.0000 C   0  0
    2.4982   -1.8861    0.0000 C   0  0
    1.7837   -1.4736    0.0000 C   0  0
    1.7770    2.1990    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  1  2  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10  5  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 10  2  0
  7 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  1
 16 18  1  0
 16 19  1  6
 18 20  1  0
 18 21  1  0
 19 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 19  1  0
 11 27  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-101125

> <Drug_Names>
L-Moses

> <SYNONYMS>
L-45

> <CA_Index_Name>
1,2-Propanediamine, N1,N1-dimethyl-N2-(3-methyl-1,2,4-triazolo[3,4-a]phthalazin-6-yl)-1-phenyl-, (1S,2S)-

> <CAS>
2079885-05-3

> <MWt>
360.46

> <Formula>
C21H24N6

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 70 77  0  0  0  0            999 V2000
   -5.0012   -2.4059    0.0000 N   0  0
   -4.9150   -1.5855    0.0000 C   0  0  1  0  0  0
   -4.1080   -1.4140    0.0000 C   0  0
   -3.6955   -2.1283    0.0000 C   0  0  2  0  0  0
   -4.2475   -2.7414    0.0000 C   0  0
   -5.5281   -1.0335    0.0000 C   0  0
   -6.3126   -1.2884    0.0000 O   0  0
   -5.3565   -0.2265    0.0000 N   0  0
   -5.9695    0.3255    0.0000 C   0  0
   -5.7980    1.1325    0.0000 C   0  0
   -6.4111    1.6845    0.0000 C   0  0
   -6.2396    2.4914    0.0000 C   0  0
   -5.4550    2.7463    0.0000 C   0  0
   -4.8419    2.1943    0.0000 C   0  0
   -5.0135    1.3874    0.0000 C   0  0
   -4.5298    3.8889    0.0000 S   0  0
   -4.6161    4.7094    0.0000 C   0  0
   -5.4230    4.8809    0.0000 N   0  0
   -5.8354    4.1664    0.0000 C   0  0
   -5.2835    3.5533    0.0000 C   0  0
   -6.6559    4.0802    0.0000 C   0  0
   -2.8750   -2.2146    0.0000 O   0  0
   -5.7156   -2.8184    0.0000 C   0  0
   -5.7156   -3.6434    0.0000 C   0  0  2  0  0  0
   -5.0012   -4.0559    0.0000 C   0  0
   -4.5887   -4.7704    0.0000 C   0  0
   -6.4300   -2.4059    0.0000 O   0  0
   -5.4137   -4.7704    0.0000 C   0  0
   -7.1445   -3.6434    0.0000 C   0  0
   -7.1445   -2.8184    0.0000 O   0  0
   -6.4300   -4.0559    0.0000 N   0  0
   -7.8590   -4.0559    0.0000 C   0  0
   -8.2715   -4.7704    0.0000 C   0  0
   -7.4465   -4.7704    0.0000 C   0  0
   -8.5735   -3.6434    0.0000 F   0  0
   -4.2867   -3.6434    0.0000 S   0  0
   -3.5723   -4.0559    0.0000 C   0  0
   -2.8578   -3.6434    0.0000 C   0  0  2  0  0  0
   -2.1433   -4.0559    0.0000 C   0  0
   -1.4289   -3.6434    0.0000 C   0  0
   -1.4289   -2.8184    0.0000 C   0  0  2  0  0  0
   -2.1433   -2.4059    0.0000 C   0  0
   -2.8578   -2.8184    0.0000 C   0  0
   -0.7145   -2.4059    0.0000 C   0  0
    0.0000   -2.8184    0.0000 N   0  0
    0.0000   -3.6434    0.0000 C   0  0
    0.7145   -4.0559    0.0000 C   0  0
    1.4289   -3.6434    0.0000 N   0  0
    1.4289   -2.8184    0.0000 C   0  0
    0.7145   -2.4059    0.0000 C   0  0
    2.1433   -4.0559    0.0000 C   0  0
    2.8578   -3.6434    0.0000 C   0  0
    3.5723   -4.0559    0.0000 C   0  0
    4.2867   -3.6434    0.0000 C   0  0
    4.2867   -2.8184    0.0000 C   0  0
    3.5723   -2.4059    0.0000 C   0  0
    2.8578   -2.8184    0.0000 C   0  0
    2.1433   -4.8809    0.0000 O   0  0
    5.0012   -4.0559    0.0000 O   0  0
    5.0012   -4.8809    0.0000 C   0  0
    5.0012   -2.4059    0.0000 N   0  0
    5.7156   -2.8184    0.0000 C   0  0
    6.4300   -2.4059    0.0000 N   0  0
    7.1445   -2.8184    0.0000 C   0  0
    7.1445   -3.6434    0.0000 C   0  0
    6.4300   -4.0559    0.0000 C   0  0
    5.7156   -3.6434    0.0000 N   0  0
    7.8590   -2.4059    0.0000 N   0  0
    8.5735   -2.8184    0.0000 C   0  0
    7.8590   -4.0559    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  6  7  2  0
  6  8  1  0
  2  6  1  6
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 10 15  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 16 20  1  0
 19 21  1  0
 13 20  1  0
  8  9  1  0
  4 22  1  1
 24 23  1  6
 24 25  1  0
 25 26  1  0
 23 27  2  0
 25 28  1  0
 29 30  2  0
 29 31  1  0
 32 33  1  0
 33 34  1  0
 32 34  1  0
 29 32  1  0
 32 35  1  0
 24 31  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 38 43  1  0
 45 46  1  0
 46 47  1  0
 47 48  1  0
 48 49  1  0
 49 50  1  0
 45 50  1  0
 51 52  1  0
 52 53  1  0
 53 54  2  0
 54 55  1  0
 55 56  2  0
 56 57  1  0
 52 57  2  0
 51 58  2  0
 59 60  1  0
 54 59  1  0
 62 63  1  0
 63 64  2  0
 64 65  1  0
 65 66  2  0
 66 67  1  0
 62 67  2  0
 68 69  1  0
 64 68  1  0
 65 70  1  0
 61 62  1  0
 55 61  1  0
 48 51  1  0
 44 45  1  0
 41 44  1  6
 38 37  1  1
 36 37  1  0
 25 36  1  0
  1 23  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-148030

> <Drug_Names>
XL01126

> <SYNONYMS>

> <CA_Index_Name>
(2S,4R)-1-((R)-3-((((1R,4R)-4-((4-(4-((5-Chloro-4-(methylamino)pyrimidin-2-yl)amino)-3-methoxybenzoyl)piperazin-1-yl)methyl)cyclohexyl)methyl)thio)-2-(1-fluorocyclopropane-1-carboxamido)-3-methylbutan
oyl)-4-

> <CAS>

> <MWt>
1019.69

> <Formula>
C50H64ClFN10O6S2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Neurological Disease

> <Target>
LRRK2; PROTACs

> <Pathway>
Autophagy; PROTAC

> <Concentration>

$$$$
Untitled Document
  SciTegic11272416012D

 29 31  0  0  0  0            999 V2000
    1.4289    0.4125    0.0000 N   0  0
    0.7145    0.8250    0.0000 C   0  0
    0.7145    1.6500    0.0000 C   0  0
    1.4289    2.0624    0.0000 C   0  0
    2.1433    1.6500    0.0000 N   0  0
    1.4289    2.8874    0.0000 O   0  0
    0.0000    2.0624    0.0000 C   0  0
   -0.7145    1.6500    0.0000 N   0  0
   -0.7145    0.8250    0.0000 C   0  0
    0.0000    0.4125    0.0000 N   0  0
   -1.4289    0.4125    0.0000 N   0  0
   -2.1433    0.8250    0.0000 C   0  0
   -2.8578    0.4125    0.0000 C   0  0  1  0  0  0
   -3.5723    0.8250    0.0000 N   0  0
   -2.8578   -0.4125    0.0000 C   0  0
   -2.1433   -0.8250    0.0000 C   0  0
   -1.4289   -0.4125    0.0000 C   0  0
    1.4289   -0.4125    0.0000 C   0  0
    2.1433   -0.8250    0.0000 C   0  0
    2.1433   -1.6499    0.0000 C   0  0
    2.8578   -2.0624    0.0000 C   0  0
    3.5723   -1.6499    0.0000 C   0  0
    2.8578   -2.8874    0.0000 C   0  0
    1.4289   -2.0624    0.0000 N   0  0
    0.7145   -1.6499    0.0000 C   0  0
    0.0000   -2.0624    0.0000 C   0  0
   -0.7145   -1.6499    0.0000 C   0  0
    0.0000   -2.8874    0.0000 C   0  0
    0.7145   -0.8250    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  3  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  2 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  6
 13 15  1  0
 15 16  1  0
 16 17  1  0
 11 17  1  0
  1 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 20 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
 25 29  1  0
 18 29  2  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-148907

> <Drug_Names>
CS640

> <SYNONYMS>

> <CA_Index_Name>
5-Pyrimidinecarboxamide, 2-[(3S)-3-amino-1-piperidinyl]-4-[[2,6-bis(1-methylethyl)-4-pyridinyl]amino]-

> <CAS>
2388506-83-8

> <MWt>
397.52

> <Formula>
C21H31N7O

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Biochemical Assay Reagents

> <Pathway>
Others

> <Concentration>

$$$$
Untitled Document
  SciTegic11272416012D

 30 34  0  0  0  0            999 V2000
   -3.7957   -2.5192    0.0000 C   0  0
   -3.2124   -1.9359    0.0000 N   0  0
   -2.4155   -2.1494    0.0000 C   0  0
   -1.8321   -1.5660    0.0000 C   0  0
   -2.0456   -0.7691    0.0000 C   0  0
   -1.2487   -0.9827    0.0000 F   0  0
   -1.4623   -0.1858    0.0000 C   0  0
   -0.6776   -0.4407    0.0000 N   0  0
   -0.4227   -1.2253    0.0000 C   0  0
    0.4023   -1.2253    0.0000 N   0  0
    0.6572   -0.4407    0.0000 C   0  0
    1.4419   -0.1858    0.0000 C   0  0
    2.0549   -0.7378    0.0000 N   0  0
    2.8396   -0.4829    0.0000 C   0  0
    3.0111    0.3241    0.0000 C   0  0
    3.7957    0.5791    0.0000 F   0  0
    2.3980    0.8761    0.0000 C   0  0
    1.6134    0.6212    0.0000 C   0  0
   -0.0102    0.0442    0.0000 C   0  0
   -0.0102    0.8692    0.0000 C   0  0
    0.7043    1.2817    0.0000 C   0  0
    0.7043    2.1067    0.0000 C   0  0
   -0.0102    2.5192    0.0000 N   0  0
   -0.7247    2.1067    0.0000 C   0  0
   -0.7247    1.2817    0.0000 C   0  0
   -1.5093    1.0268    0.0000 C   0  0
   -1.9942    1.6942    0.0000 C   0  0
   -1.5093    2.3617    0.0000 N   0  0
   -2.8425   -0.5556    0.0000 C   0  0
   -3.4259   -1.1390    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 12 18  1  0
 11 19  2  0
  8 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 20 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 24 28  1  0
  5 29  1  0
 29 30  1  0
  2 30  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-148251

> <Drug_Names>
MU1742

> <SYNONYMS>

> <CA_Index_Name>
4-(1-((4-Fluoro-1-methylpiperidin-4-yl)methyl)-4-(5-fluoropyridin-2-yl)-1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine

> <CAS>

> <MWt>
408.45

> <Formula>
C22H22F2N6

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Casein Kinase

> <Pathway>
Cell Cycle/DNA Damage; Stem Cell/Wnt

> <Concentration>

$$$$
Untitled Document
  SciTegic11272416012D

 35 37  0  0  0  0            999 V2000
   -0.8813    1.1856    0.0000 N   0  0
   -0.0535    1.1856    0.0000 N   0  0
   -1.1370    0.3983    0.0000 C   0  0
   -0.4674   -0.0882    0.0000 S   0  0
    0.2023    0.3983    0.0000 C   0  0
   -1.9216    0.1434    0.0000 C   0  0
   -2.5346    0.6954    0.0000 C   0  0
   -2.3626    1.5051    0.0000 C   0  0
   -2.9777    2.0590    0.0000 C   0  0
   -3.7650    1.8032    0.0000 C   0  0
   -3.9371    0.9935    0.0000 C   0  0
   -3.3219    0.4396    0.0000 C   0  0
   -4.3781    2.3551    0.0000 C   0  0
    0.9868    0.1434    0.0000 N   0  0
    1.5999    0.6954    0.0000 C   0  0
    1.4284    1.5023    0.0000 O   0  0
    2.3844    0.4405    0.0000 C   0  0  2  0  0  0
    2.5559   -0.3664    0.0000 N   0  0
    2.9975    0.9924    0.0000 C   0  0
    2.8259    1.7994    0.0000 C   0  0
    2.0414    2.0542    0.0000 C   0  0
    3.4390    2.3513    0.0000 C   0  0
    3.3405   -0.6213    0.0000 C   0  0
    3.9535   -0.0693    0.0000 O   0  0
    3.5120   -1.4282    0.0000 C   0  0
    2.6856   -1.4756    0.0000 C   0  0
    2.3134   -2.2151    0.0000 C   0  0
    2.7676   -2.9070    0.0000 C   0  0
    3.5941   -2.8596    0.0000 C   0  0
    3.9663   -2.1203    0.0000 C   0  0
    4.2733   -1.1106    0.0000 C   0  0
    4.3790   -0.2925    0.0000 F   0  0
    4.9290   -1.6112    0.0000 F   0  0
    4.9902   -0.6968    0.0000 F   0  0
   -4.9902    2.9070    0.0000 N   0  0
  1  2  1  0
  1  3  2  0
  3  4  1  0
  4  5  1  0
  5  2  2  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 10 13  1  0
  5 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 17 19  1  1
 19 20  1  0
 20 21  1  0
 20 22  1  0
 18 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 25  1  0
 25 31  1  0
 31 32  1  0
 31 33  1  0
 31 34  1  0
 13 35  3  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-153045

> <Drug_Names>
BAY-805

> <SYNONYMS>

> <CA_Index_Name>
Cyclohexanecarboxamide, N-[(1R)-1-[[[5-[(4-cyanophenyl)methyl]-1,3,4-thiadiazol-2-yl]amino]carbonyl]-3-methylbutyl]-1-(trifluoromethyl)-

> <CAS>
2925481-88-3

> <MWt>
507.57

> <Formula>
C24H28F3N5O2S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Deubiquitinase

> <Pathway>
Cell Cycle/DNA Damage

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 25 28  0  0  0  0            999 V2000
    1.3059   -2.0279    0.0000 N   0  0
    1.9733   -1.5430    0.0000 C   0  0
    1.7184   -0.7584    0.0000 C   0  0
    0.8934   -0.7584    0.0000 C   0  0
    0.3413   -0.1453    0.0000 C   0  0
   -0.4656   -0.3168    0.0000 C   0  0
   -0.7206   -1.1014    0.0000 C   0  0
   -0.1686   -1.7145    0.0000 C   0  0
    0.6384   -1.5430    0.0000 C   0  0
    2.1729   -0.0699    0.0000 C   0  0
    2.9945    0.0041    0.0000 C   0  0
    3.5647   -0.5922    0.0000 C   0  0
    3.4539   -1.4098    0.0000 C   0  0
    2.7457   -1.8329    0.0000 C   0  0
    2.0448    1.3533    0.0000 C   0  0
    1.6980    0.6047    0.0000 N   0  0
    3.3413    0.7527    0.0000 C   0  0
    2.8664    1.4273    0.0000 N   0  0
    1.5699    2.0279    0.0000 N   0  0
   -1.0177    0.2963    0.0000 C   0  0
   -1.6010    0.8796    0.0000 C   0  0
   -2.1844    1.4630    0.0000 C   0  0
   -2.9813    1.2495    0.0000 N   0  0
   -3.5647    1.8328    0.0000 C   0  0
   -3.1948    0.4526    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  1  9  1  0
  4  9  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 15 16  1  0
 17 18  1  0
 15 18  2  0
 16 10  2  0
 17 11  2  0
 14  2  1  0
 10  3  1  0
 15 19  1  0
 20 21  3  0
 21 22  1  0
 23 24  1  0
 23 25  1  0
 22 23  1  0
  6 20  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-151473

> <Drug_Names>
PIKfyve-IN-1

> <SYNONYMS>

> <CA_Index_Name>
Pyrimido[42,52:3,4]cyclohept[1,2-b]indol-2-amine, 11-[3-(dimethylamino)-1-propyn-1-yl]-5,6,7,8-tetrahydro-

> <CAS>
2857982-26-2

> <MWt>
331.41

> <Formula>
C20H21N5

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer; Infection

> <Target>
PIKfyve

> <Pathway>
PI3K/Akt/mTOR

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 34 37  0  0  0  0            999 V2000
    4.6440    1.2375    0.0000 O   0  0
    4.6440    0.4125    0.0000 C   0  0
    5.3583    0.0000    0.0000 N   0  0
    3.9295    0.0000    0.0000 C   0  0
    3.2150    0.4125    0.0000 C   0  0
    3.2150    1.2375    0.0000 F   0  0
    2.5005    0.0000    0.0000 C   0  0
    2.5005   -0.8250    0.0000 C   0  0
    3.2150   -1.2375    0.0000 C   0  0
    3.9295   -0.8250    0.0000 C   0  0
    4.6440   -1.2375    0.0000 O   0  0
    5.3583   -0.8250    0.0000 C   0  0
    1.7861   -1.2375    0.0000 C   0  0
    1.7861   -2.0624    0.0000 C   0  0
    1.0717   -2.4749    0.0000 N   0  0
    0.3572   -2.0624    0.0000 C   0  0
    0.3572   -1.2375    0.0000 C   0  0
   -0.3572   -0.8250    0.0000 C   0  0
   -1.0717   -1.2375    0.0000 C   0  0
   -1.7861   -0.8250    0.0000 C   0  0
   -1.7861    0.0000    0.0000 C   0  0
   -1.0717    0.4125    0.0000 C   0  0
   -0.3572    0.0000    0.0000 C   0  0
   -2.5005    0.4125    0.0000 N   0  0
   -3.2150    0.0000    0.0000 C   0  0
   -3.9295    0.4125    0.0000 C   0  0
   -3.9295    1.2375    0.0000 N   0  0
   -3.2150    1.6500    0.0000 C   0  0
   -2.5005    1.2375    0.0000 C   0  0
   -4.6440    1.6500    0.0000 C   0  0
   -4.6440    2.4749    0.0000 C   0  0
   -5.3583    1.2375    0.0000 C   0  0
    1.0717   -0.8250    0.0000 C   0  0
    1.0717    0.0000    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  4 10  1  0
 10 11  1  0
 11 12  1  0
  8 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 18 23  1  0
 21 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 24 29  1  0
 27 30  1  0
 30 31  1  0
 30 32  1  0
 17 33  2  0
 13 33  1  0
 33 34  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-148234

> <Drug_Names>
M4K2234

> <SYNONYMS>

> <CA_Index_Name>
Benzamide, 2-fluoro-6-methoxy-4-[4-methyl-5-[4-[4-(1-methylethyl)-1-piperazinyl]phenyl]-3-pyridinyl]-

> <CAS>
2421141-51-5

> <MWt>
462.56

> <Formula>
C27H31FN4O2

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Anaplastic lymphoma kinase (ALK)

> <Pathway>
Protein Tyrosine Kinase/RTK

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 31 34  0  0  0  0            999 V2000
    1.6816    2.5503    0.0000 C   0  0
    1.8951    1.7534    0.0000 S   0  0
    2.6920    1.9670    0.0000 O   0  0
    1.0982    1.5399    0.0000 O   0  0
    2.1087    0.9565    0.0000 N   0  0
    1.5252    0.3732    0.0000 C   0  0
    2.9055    0.7430    0.0000 C   0  0
    3.1191   -0.0539    0.0000 C   0  0
    3.9160   -0.2674    0.0000 C   0  0
    4.4993    0.3160    0.0000 C   0  0
    4.2858    1.1129    0.0000 C   0  0
    3.4889    1.3264    0.0000 N   0  0
    2.5356   -0.6372    0.0000 C   0  0
    1.7287   -0.4657    0.0000 N   0  0
   -0.1823   -1.5204    0.0000 C   0  0
    0.3697   -0.9073    0.0000 N   0  0
    1.1766   -1.0789    0.0000 C   0  0
    1.4316   -1.8635    0.0000 C   0  0
    0.8796   -2.4765    0.0000 C   0  0
    0.0726   -2.3050    0.0000 N   0  0
   -0.9894   -1.3489    0.0000 C   0  0
   -1.6025   -1.9009    0.0000 N   0  0
   -2.3170   -1.4884    0.0000 C   0  0
   -2.1454   -0.6815    0.0000 C   0  0
   -1.3249   -0.5952    0.0000 N   0  0
   -3.1016   -1.7434    0.0000 C   0  0
   -3.7147   -1.1914    0.0000 C   0  0
   -3.5432   -0.3843    0.0000 C   0  0
   -2.7585   -0.1294    0.0000 C   0  0
   -3.2731   -2.5503    0.0000 F   0  0
   -4.4993   -1.4462    0.0000 Cl  0  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  1  2  1  0
  5  6  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  7 12  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 15 20  2  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 21 25  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 24  2  0
 26 23  2  0
 26 30  1  0
 27 31  1  0
 15 21  1  0
 14 17  1  0
 13 14  1  0
  8 13  1  0
  5  7  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-148518

> <Drug_Names>
MSC-1186

> <SYNONYMS>

> <CA_Index_Name>
Methanesulfonamide, N-[3-[[[2-(6-chloro-7-fluoro-1H-benzimidazol-2-yl)-4-pyrimidinyl]amino]methyl]-2-pyridinyl]-N-methyl-

> <CAS>
2871698-23-4

> <MWt>
461.90

> <Formula>
C19H17ClFN7O2S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
SRPK

> <Pathway>
Cell Cycle/DNA Damage

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 29 32  0  0  0  0            999 V2000
   -1.2789   -2.3500    0.0000 O   0  0
   -1.1239   -1.5397    0.0000 C   0  0
   -1.7482   -1.0003    0.0000 N   0  0
   -2.5275   -1.2713    0.0000 C   0  0
   -2.6824   -2.0817    0.0000 C   0  0
   -3.3066   -1.5423    0.0000 C   0  0
   -3.1517   -0.7320    0.0000 C   0  0
   -0.3447   -1.2687    0.0000 C   0  0
    0.2653   -1.8242    0.0000 C   0  0
    1.0633   -1.6151    0.0000 C   0  0
    1.3227   -0.8319    0.0000 C   0  0
    0.6082   -0.4194    0.0000 C   0  0
   -0.2110   -0.4546    0.0000 C   0  0
   -0.6604    0.2373    0.0000 O   0  0
   -1.4809    0.1511    0.0000 C   0  0
   -1.8164    0.9048    0.0000 C   0  0
   -1.2033    1.4568    0.0000 O   0  0
   -1.0318    2.2638    0.0000 C   0  0
   -0.2113    2.3500    0.0000 C   0  0
    0.1242    1.5963    0.0000 N   0  0
    0.9481    1.5531    0.0000 C   0  0
    1.3227    0.8181    0.0000 N   0  0
    2.0371    0.4056    0.0000 C   0  0
    2.0371   -0.4194    0.0000 C   0  0
    2.8217   -0.6744    0.0000 C   0  0
    3.3066   -0.0069    0.0000 N   0  0
    2.8217    0.6605    0.0000 N   0  0
    2.4889    1.4154    0.0000 C   0  0
    1.7441    1.7702    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  2  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  8 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 11 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 23 27  1  0
 27 28  1  0
 28 29  2  0
 21 29  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-149006

> <Drug_Names>
CK156

> <SYNONYMS>

> <CA_Index_Name>
(13Z,14E)-N-(tert-Butyl)-3,6-dioxa-9-aza-1(3,5)-pyrazolo[1,5-a]pyrimidina-2(1,3)-benzenacyclononaphane-24-carboxamide

> <CAS>
2910938-59-7

> <MWt>
395.45

> <Formula>
C21H25N5O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Inflammation/Immunology; Cancer

> <Target>
DAPK

> <Pathway>
Apoptosis

> <Concentration>

$$$$
Untitled Document
  SciTegic11272416012D

 35 39  0  0  0  0            999 V2000
    2.1433   -3.2999    0.0000 N   0  0
    1.4289   -2.0624    0.0000 C   0  0
    1.4289   -2.8874    0.0000 C   0  0  2  0  0  0
    0.7145   -3.2999    0.0000 C   0  0
    0.0000   -2.8874    0.0000 O   0  0
    0.0000   -2.0624    0.0000 C   0  0  1  0  0  0
    0.7145   -1.6500    0.0000 O   0  0
   -0.7145   -1.6500    0.0000 C   0  0
    0.0000    2.0624    0.0000 Cl  0  0
    2.1433    3.2999    0.0000 F   0  0
    3.5723    1.6500    0.0000 N   0  0
    4.2867    2.0624    0.0000 C   0  0
    4.2867    2.8874    0.0000 C   0  0
    3.5723    3.2999    0.0000 C   0  0
    2.8578    2.8874    0.0000 C   0  0
    2.8578    2.0624    0.0000 C   0  0
    1.4289    0.4125    0.0000 C   0  0
    2.1433    0.8250    0.0000 C   0  0
    2.1433    1.6500    0.0000 C   0  0
    1.4289    2.0624    0.0000 C   0  0
    0.7145    1.6500    0.0000 C   0  0
    0.7145    0.8250    0.0000 C   0  0
   -4.2867   -0.4125    0.0000 C   0  0
   -3.5723   -0.8250    0.0000 N   0  0
    0.7145   -0.8250    0.0000 O   0  0
   -0.7145   -0.8250    0.0000 N   0  0
    0.0000   -0.4125    0.0000 C   0  0
    0.0000    0.4125    0.0000 C   0  0
   -0.7145    0.8250    0.0000 C   0  0
   -2.8578    0.4125    0.0000 N   0  0
   -2.1433    0.8250    0.0000 C   0  0
   -1.4289    0.4125    0.0000 C   0  0
   -1.4289   -0.4125    0.0000 C   0  0
   -2.1433   -0.8250    0.0000 N   0  0
   -2.8578   -0.4125    0.0000 C   0  0
 26  8  1  0
  6  8  1  6
  3  1  1  1
  7  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  6  5  1  0
  7  6  1  0
 28 22  1  0
 21  9  1  0
 19 16  1  0
 15 10  1  0
 16 11  2  0
 12 11  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 16 15  1  0
 22 17  2  0
 18 17  1  0
 19 18  2  0
 20 19  1  0
 21 20  2  0
 22 21  1  0
 35 24  1  0
 24 23  1  0
 27 25  2  0
 29 32  1  0
 26 33  1  0
 27 26  1  0
 28 27  1  0
 29 28  2  0
 35 30  2  0
 31 30  1  0
 32 31  2  0
 33 32  1  0
 34 33  2  0
 35 34  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-139253

> <Drug_Names>
MRIA9

> <SYNONYMS>

> <CA_Index_Name>
8-(((2r,5r)-5-Amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-fluoropyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one

> <CAS>
2750707-05-0

> <MWt>
496.92

> <Formula>
C24H22ClFN6O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Apoptosis; PAK; Salt-inducible Kinase (SIK)

> <Pathway>
Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton; Immunology/Inflammation

> <Concentration>

$$$$
Untitled Document
  SciTegic11272416012D

 25 27  0  0  0  0            999 V2000
    5.4689    1.8734    0.0000 N   0  0
    4.8014    1.3885    0.0000 C   0  0
    4.1340    0.9036    0.0000 N   0  0
    4.1340    0.0786    0.0000 C   0  0
    3.3494   -0.1764    0.0000 C   0  0
    2.8645    0.4911    0.0000 C   0  0  2  0  0  0
    2.0395    0.4911    0.0000 C   0  0
    1.6270    1.2055    0.0000 O   0  0
    1.6270   -0.2234    0.0000 N   0  0
    0.8020   -0.2234    0.0000 C   0  0
    0.3170    0.4440    0.0000 N   0  0
   -0.4676    0.1891    0.0000 C   0  0
   -0.4676   -0.6359    0.0000 C   0  0
   -1.1821   -1.0484    0.0000 C   0  0
   -1.8965   -0.6359    0.0000 N   0  0
   -2.6110   -1.0484    0.0000 C   0  0
   -2.6110   -1.8734    0.0000 O   0  0
   -3.3255   -0.6359    0.0000 C   0  0
   -4.0399   -1.0484    0.0000 N   0  0
   -4.7544   -0.6359    0.0000 N   0  3
   -5.4689   -0.2234    0.0000 N   0  5
   -1.8965    0.1891    0.0000 C   0  0
   -1.1821    0.6016    0.0000 C   0  0
    0.3170   -0.8908    0.0000 S   0  0
    3.3494    1.1585    0.0000 C   0  0
  1  2  3  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  6
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  2  0
 15 22  1  0
 22 23  1  0
 12 23  1  0
 13 24  1  0
 10 24  1  0
  6 25  1  0
  3 25  1  0
M  CHG  2  20   1  21  -1
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-148254

> <Drug_Names>
8RK64

> <SYNONYMS>

> <CA_Index_Name>
3-Pyrrolidinecarboxamide, N-[5-(2-azidoacetyl)-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl]-1-cyano-, (3S)-

> <CAS>
2705841-52-5

> <MWt>
360.39

> <Formula>
C14H16N8O2S

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Cancer

> <Target>
Deubiquitinase

> <Pathway>
Cell Cycle/DNA Damage

> <Concentration>
10mM

$$$$
Untitled Document
  SciTegic11272416012D

 27 29  0  0  0  0            999 V2000
    2.1434    1.8563    0.0000 O   0  0
    2.1434    1.0313    0.0000 C   0  0
    2.8579    0.6187    0.0000 O   0  0
    3.5724    1.0313    0.0000 C   0  0
    3.5724    1.8563    0.0000 C   0  0
    4.2868    1.4437    0.0000 C   0  0
    4.2868    0.6187    0.0000 C   0  0
    1.4289    0.6187    0.0000 N   0  0
    1.4289   -0.2062    0.0000 C   0  0
    0.7145   -0.6187    0.0000 C   0  0
    0.0000   -0.2062    0.0000 N   0  0
   -0.7145   -0.6187    0.0000 C   0  0
   -1.4289   -0.2062    0.0000 C   0  0
   -2.1434   -0.6187    0.0000 C   0  0
   -2.1434   -1.4437    0.0000 N   0  0
   -1.4289   -1.8563    0.0000 N   0  0
   -0.7145   -1.4437    0.0000 C   0  0
    0.0000   -1.8563    0.0000 N   0  0
   -2.8579   -0.2062    0.0000 C   0  0
   -3.5724   -0.6187    0.0000 C   0  0
   -4.2868   -0.2062    0.0000 C   0  0
   -4.2868    0.6187    0.0000 C   0  0
   -3.5724    1.0313    0.0000 C   0  0
   -2.8579    0.6187    0.0000 C   0  0
   -2.1434    1.0313    0.0000 O   0  0
    0.0000    0.6187    0.0000 C   0  0
    0.7145    1.0313    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  2  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12 17  2  0
 17 18  1  0
 14 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 19 24  1  0
 24 25  1  0
 11 26  1  0
 26 27  1  0
  8 27  1  0
M  END
> <Name>
Untitled Document

> <Catalog_No>
HY-145446

> <Drug_Names>
SGC-SMARCA-BRDVIII

> <SYNONYMS>

> <CA_Index_Name>
1-Piperazinecarboxylic acid, 4-[3-amino-6-(2-hydroxyphenyl)-4-pyridazinyl]-, 1,1-dimethylethyl ester

> <CAS>
1997319-84-2

> <MWt>
371.43

> <Formula>
C19H25N5O3

> <ClinicalInformation>
No Development Reported

> <ResearchArea>
Metabolic Disease

> <Target>
Epigenetic Reader Domain

> <Pathway>
Epigenetics

> <Concentration>
10mM

$$$$
